What happened

Engaging in the arts, whether directly or by going to museums or concerts, helps people age more slowly, British researchers reported Monday in the journal Innovation in Aging. The benefits were found to be comparable to physical exercise and quitting smoking. They were most pronounced for people over 40 and those who engage in a wider range of artistic endeavors.

Who said what

The University College London researchers looked at how often 3,556 adults in the U.K. engaged in some artistic pursuit — singing, painting, dancing, crafting, photography — or visited an exhibition or heritage site. Those who did so weekly aged 4% slower in blood tests of their “epigenetic clock,” or biological aging. “People were around a year younger biologically if they’re regularly engaged in the arts,” researcher Daisy Fancourt, the study’s lead author, told NPR. Monthly arts engagement slowed aging by 3%.

Slower biological aging “does not necessarily mean someone will live longer,” The Guardian said, but “previous studies have suggested a link between arts engagement and longer lifespan.”

What next?

The research “builds on a growing body of evidence” that arts activities “reduce stress, lower inflammation and improve cardiovascular disease risk,” study senior author Feifei Bu told The Guardian. Regular creative engagement should be treated not “as a luxury” but “an essential,” Fancourt told The Art Newspaper, “just like we promote 10,000 steps a day or five-a-day of fruits and vegetables.”

What happened

Food and Drug Administration chief Dr. Marty Makary resigned Tuesday after a tumultuous 13 months leading the agency charged with regulating drugs, medical devices, vaccines and much of the U.S. food supply. The White House and Health and Human Services Department “agreed in recent days on the need to replace” him, The Washington Post said. “Marty is a great guy,” President Donald Trump, who posted Makary’s resignation message on social media, told reporters. But “he was having some difficulty.”

Who said what

“In the end,” Makary “had just about run out of allies,” having upset “rare-disease patients, antiabortion groups and some drug-industry leaders,” The Wall Street Journal said. Makary also “drew criticism from public health leaders who viewed him as pandering to anti-vaccine activists,” The New York Times said. But according to his confidantes, he “ultimately left over concerns about the administration’s decision to authorize fruit-flavored e-cigarettes,” a move Trump insisted on but Makary opposed “over concerns that fruity and candy flavors would lure young people to addictive vapes.”

Makary had some “strong ideas” about streamlining the drug review process, Matthew Herper said at Stat News, but he was the FDA’s “worst commissioner” in at least 25 years. He “offended almost everyone involved in FDA issues, which is not easy to do,” National Center for Health Research president Diana Zuckerman told the Times. “But it would still be a disaster if he is replaced by someone who appeals primarily to tobacco companies, anti-abortion activists” and pharmaceutical lobbyists.

What next?

Trump appointed Kyle Diamantas, the FDA’s top food regulator, as acting commissioner.

‘We’re thinking about mental health diagnoses all wrong’

Awais Aftab at The New York Times

For “decades, the public conversation about mental health has been routed through the categories in the Diagnostic and Statistical Manual of Mental Disorders, or DSM,” says Awais Aftab. These “have been convenient for professional communication, insurance billing and conducting clinical trials, but they have given the false impression that each mental disorder is a relatively distinct problem with clear boundaries.” They “can capture something useful and inform treatment options, but none of them do justice” to the “nature of mental illness.”

Read more

‘What Jews can learn from the pope’

Kenneth Seeskin at the Chicago Tribune

Pope Leo XIV is a “distinguished proponent of peace, human dignity and concern for disadvantaged people,” says Kenneth Seeskin. While “there is no one in Judaism who speaks with the authority of a pope, as people of God, Jews also face the question of how to make sense of an ancient and not always consistent tradition.” The “Jewish community is deeply divided over Israel’s actions in Gaza,” and “Jews must ask the same questions of their religion.”

Read more

‘Here comes the slop’

Heather Schwedel at Slate

Many “photos of wedding dresses” have “either been designed or enhanced by AI,” says Heather Schwedel. If “you’re shopping for a wedding dress in 2026, you’re almost guaranteed to encounter at least a little slop.” As AI’s “popularity with everyday consumers has grown over the past few years, it’s taken hold in seemingly every medium,” and “even knitters are having to learn to separate real patterns from the AI-generated ones. Of course wedding dresses aren’t immune.”

Read more

‘Rethinking transitional justice in Bosnia’

Jared O. Bell at Foreign Policy

The U.S. and EU “have treated constitutional reform and war crimes accountability as the primary metrics of progress in Bosnia and Herzegovina,” says Jared O. Bell. If Bosnia “has not unified its narratives of the past or produced visibly contrite leaders, Western logic goes, then it has ‘failed.’” But Bosnia’s “most consequential peace process” is “unfolding in factories, logistics hubs, municipal utilities and cross-entity supply chains — in the daily economic life that keeps the country running.”

Read more

What happened

The Dutch cruise ship at the center of the hantavirus outbreak docked off Spain’s Canary Islands on Sunday so passengers could be evacuated to their home countries. They included all 17 American passengers from the MV Hondius, one of whom tested positive for the virus Sunday while another developed mild symptoms, the U.S. Health and Human Services Department said. One of five French passengers also tested positive after showing symptoms on the flight home, the French government said. Three passengers have died since April 11 and at least five others have fallen ill with hantavirus symptoms.

Who said what

Hantavirus is a rare and deadly virus usually spread by inhaling rodent droppings, but the Andes strain found in the infected passengers can spread through close human contact, the World Health Organization said. “This is not another Covid,” WHO Director-General Tedros Adhanom Ghebreyesus said. “And the risk to the public is low.”

What next?

The U.S. passengers are arriving in Omaha on Monday morning, where most will be monitored at the specialized National Quarantine Unit while the one who tested positive will be transferred to the Nebraska Biocontainment Unit, HHS said.

The Trump administration has lofty expectations about the state of the pharmaceutical industry, but not everyone appears to be a believer. Recent data from the White House predicted that the administration’s deals with drug companies could save the economy more than half a trillion dollars over the next decade. While Republicans are lauding this estimate, many Democrats are taking it with a grain of salt.

‘Touted his drug pricing deals as transformative’

The White House predicts that Trump’s deals could save $529 billion over the next 10 years, according to an analysis of data obtained by The Associated Press. The administration also estimated that federal and state governments could “save a combined $64.3 billion on Medicaid during the next decade” because of Trump’s agreements, Josh Doak said at the AP.

Trump administration officials have touted the president’s “drug pricing deals as transformative and urged Congress to codify their principles into law” as part of “most favored nation” (MFN) pricing, said Doak. The White House has “reached voluntary agreements with 17 pharmaceutical companies,” and it appears the administration’s “goal is to bring manufacturers of sole-source brand-name drugs and biologics into comparable arrangements,” Colleen Cabili said at Quartz. Details on the deal specifics remain unclear.

The president has “sought to position his pharmaceutical pricing push as a winning issue with voters,” said Cabili. Given his plummeting poll numbers over affordability, Trump has been “focusing on his efforts to cut deals with companies so that the cost of prescription drugs in the U.S. would no longer be dramatically higher than in other affluent nations,” said Doak.

The mechanism ‘remains a black box’

Despite the White House’s optimism, many across the aisle are skeptical of the Trump administration’s potential cost savings. Just prior to the White House’s analysis, 17 Democratic senators introduced legislation that would force Trump to provide details of the drug deals. If “these deals are actually lowering costs for patients, show us,” Sen. Mark Kelly (D-Ariz.), one of the co-sponsors of the legislation, said in a statement. “Americans deserve transparency.”

If “these deals are so great, why is the Trump administration afraid of showing them to the public? Because Trump is a giant fraud when it comes to lower drug prices,” Sen. Ron Wyden (D-Ore.) said in a parallel statement. The “scope of the savings claimed by the Trump administration are likely to intensify the scrutiny by Democrats,” said Doak at the AP. One of their primary concerns is that “pharmaceutical companies have increased their profit margins while working with the administration.”

The “exact mechanism” for these savings “remains a black box,” said Angus Liu at the biopharma news website Fierce Pharma. Beyond the price of the drugs themselves, the White House “has yet to define how commercial markets, such as employer-sponsored insurance, will access those discounted rates.” The “math for these massive savings only adds up if the administration can expand its circle of agreements beyond the 17 Big Pharma firms initially targeted” by Trump. Many biotech companies are also wary of “MFN’s impact on their business models” and “argue that they lack the diverse portfolios of pharma companies that can absorb revenue hits from pricing pressure.”

What if a cling wrap could fight disease? A newly developed plastic film has successfully killed viruses on contact. The material could be easily mass-produced and doesn’t have to be reapplied. In the future, it may even replace traditional chemical cleaners.

Predatory plastic

Scientists have created a thin, acrylic film that can kill viruses, according to a study published in the journal Advanced Science. The film contains nanopillars, which are “ultra‑fine structures” that “grab and stretch the outer shell of the virus so much that it ruptures, killing the virus through mechanical force rather than chemical disinfectants,” said a press release about the study. The material was tested on human parainfluenza virus 3 (hPIV-3), which causes bronchiolitis and pneumonia, and it “successfully killed (or damaged irreparably) 94% of the viruses with which it came into contact after just one hour,” said Popular Mechanics.

There have been other surface viral disinfectants developed, but these “often involve incorporating materials such as graphene or tannic acid and other natural agents into personal protective equipment such as masks, gloves, goggles, hard hats and respirators,” Elena Ivanova, a professor of physics at RMIT University and senior author of the study, said at The Conversation. While efficient, these disinfectants “can pose a risk to human health” and may also be “environmental hazards due to chemical leaching.” Plus they have “declining effectiveness over time as the potency of the active ingredients weakens.”

Other disinfectants, like wipes and sprays, require more effort. Disinfectant “must remain wet for some time to kill germs,” said Ivanova. The surfaces can also be “recontaminated quickly when other people touch them.” Acrylic films, by contrast, are “continually effective (meaning they don’t have to be reapplied over and over again), they don’t harm the environment and they don’t contribute to antimicrobial resistance,” said Popular Mechanics. The film is also much more scalable and could potentially be produced in a similar manner to cling wrap.

Film of the future

While the plastic film shows promise, we are not quite at the place to replace current disinfectants with it. The product was tested only on hPIV‑3, which is an “enveloped virus with a fatty outer membrane,” said the release. This membrane makes it more conducive to getting caught and being ripped apart by the nanopillars. Researchers are now planning to “test smaller and nonenveloped viruses to see how broadly the nanotextured surface works.”

The effectiveness of the nanotexture also depends on the distance between each pillar. The closer the features are together, the more virus-fighting ability the film has. There need to be “more tests on curved surfaces, which — by their geometric nature — spread the pillars apart,” said Popular Mechanics. The material can also degrade over time.

“As nanofabrication tools get better, our results give a clearer guide to which nanopatterns work best to kill viruses,” Samson Mah, the lead author of the study, said in a press release. “We could one day have surfaces like phone screens, keyboards and hospital tables covered with this film, killing viruses on contact without using harsh chemicals.”

The thymus is a small organ behind the breastbone that helps to establish the body’s immune system early in life. Since it shrinks with age, it was once thought to become mostly inactive over time. And many people have had their thymus removed, primarily as a treatment for myasthenia gravis. But this mini organ may be mightier than expected.

The organ has been “overlooked for decades and may be a missing piece in explaining why people age differently and why cancer treatments fail in some patients,” said Hugo Aerts, a corresponding author on both studies, in a press release. And now two different studies published in the journal Nature — one connecting the long-term health of adults with their thymic health and the other analyzing cancer therapy outcomes and thymic health — point to the thymus playing an important role in wellness.

T-cells and immunity

The thymus’ main function is to “generate a diverse T-cell repertoire, which provides adaptive immunity throughout life,” said the Nature study on thymic long-term health consequences. While the “relevance and abundance of the T-cell repertoire at a young age are well documented,” it’s likely that the thymus “retains a continued role in T-cell production throughout adulthood and that the pattern of decline of thymic function in adults is associated with poorer health outcomes.”

Higher thymic health scores are “associated with laboratory markers of continued T-cell production, greater T-cell diversity in blood and tumors, and stronger activity of immune pathways, supporting thymic health as a proxy for immune competence,” said the press release. “When thymic health and T-cell diversity decline, the immune system becomes less able to respond to new threats, like cancer or other diseases.”

Surprising health indicator

People with better thymic health had “about a 50% lower risk of premature death, 63% lower risk of cardiovascular death, and 36% lower risk of developing lung cancer compared to those with low thymic health,” said the release. Researchers saw “similar patterns across many other causes of death, suggesting that thymic health may reflect overall immune resilience.”

A healthy thymus is also “associated with reduced risks of progression and all-cause mortality” in cancer patients, said the Nature study on thymic health and cancer. The outcomes were especially positive for those with lung cancer. People with “healthier thymuses were more likely to respond to cancer immunotherapy drugs, which trigger the immune system to fight cancer, but don’t work for many patients,” said The Washington Post. Because of the T-cells’ role in immunity, those with their thymus removed can also have an “increased risk of autoimmune disease,” said a 2023 study published in The New England Journal of Medicine.

Future solutions

The general health of the thymus can be influenced by “lifestyle and metabolic health measures, such as smoking, physical activity or HDL levels,” said the long-term health consequences study. Thymic decay is “highly individualized even in presumed healthy adults, indicating that thymic function can also be substantially reduced in individuals who did not have their thymus surgically removed.” While the thymus cannot be directly attributed to better health outcomes, there are now “new leads to be explored,” said the Post.

In the future, it might be possible to “engineer a thymus from an organ donor to help people who receive transplants tolerate their new organ without taking harsh anti-rejection drugs,” said the Post. There’s also interest in “probing whether there are ways to slow down the thymus’ natural deterioration,” which could have “many applications in autoimmune diseases, improving people’s responses to vaccinations as they age or improving how people respond to cancer immunotherapies.”

Hantavirus is typically spread by exposure to rodent droppings. That’s concerning enough. But health experts are alarmed that a deadly ship-borne outbreak of hantavirus might be spreading from human to human.

The possibility of person-to-person transmission of hantavirus is “very, very surprising and obviously a very rare occurrence,” Kari Debbink of Johns Hopkins Bloomberg School of Public Health said to NPR. Three people aboard the MV Hondius cruise ship have already died from the outbreak, and there are several other suspected cases among the 147 passengers and crew.

A typical rodent-caused outbreak could be resolved by “taking people off the ship,” the University of Michigan’s Emily Abdoler said to the network. But the possibility of a human-transmitted disease means “taking folks off the ship doesn’t stop the spread.”

Passengers aboard the Hondius have been isolated in their cabins in a “lockdown reminiscent of the Covid-19 pandemic,” said The Associated Press. Authorities are being cautious but also warning the public against panic. The Andes strain of hantavirus at issue “requires very close, prolonged contact” to spread between people, KFF Health News’ Céline Gounder said on “PBS NewsHour.” That’s “very different” from Covid or flu viruses that can be “transmitted much more easily through the airborne respiratory route.”

What did the commentators say?

The outbreak is “serious and frankly a bit unnerving,” Katherine J. Wu said at The Atlantic. A human-transmitted hantavirus could “pose an additional threat” to people at the ship’s destination or to healthcare workers treating the sick. The ship’s passengers will eventually disembark, but officials cannot yet say the risk that passengers and crew “will pose to the broader global community.” Making the investigation more difficult: The cruise ship environment where “strangers are constantly schmoozing” makes it easy for people-to-people viruses to spread but difficult for medical professionals to track the source.

There’s “no reason for panic,” Lisa Jarvis said at Bloomberg. A “handful of cases of a deadly virus” is understandably sufficient to “raise all our hackles” following the Covid pandemic. Hantavirus is “ubiquitous” in parts of the United States such as the desert Southwest, while actual “infections are still rare.” The current outbreak is “unlikely to turn into anything bigger.”

The World Health Organization was “built to manage” emergencies like this, Krutika Kuppalli said at Stat News. Indeed, the WHO is “coordinating the response.” But the U.S. government has not been able to take advantage of the information generated by the agency, having withdrawn from the WHO in 2025. And the outbreak should be a “warning sign to the U.S.” of the costs of that decision.

What next?

The Hondius “remains at sea” while regional leaders “clash over its docking,” said The New York Times. Spain has said the ship can dock in the Canary Islands, but regional government officials have “objected to the ship docking there.” The isolated passengers are keeping themselves busy with “reading, watching movies, having hot drinks and that kind of thing,” said travel influencer Kasem Hato to the Times.

Life on board the MV Hondius has turned from a dream adventure to a tragic nightmare after the outbreak of hantavirus.

Three people were today evacuated from the boat that is currently off the coast of Cape Verde. The patients – British, German, and Dutch nationals – are being taken to the Netherlands to receive medical care. In addition to the three passengers who died earlier in the cruise, five other people are thought to have symptoms consistent with an outbreak of hantavirus.

Though the “overall public health risk remains low”, the World Health Organization is closely monitoring the health of passengers and crew on board the ship, said WHO director general Tedros Adhanom Ghebreyesus.

Earlier, the Canary Islands government announced its opposition to Spain’s plan to allow the Hondius to dock there. Its originally intended destination, Cape Verde, had also refused the ship entry.

‘Tragic echoes’ of Covid

When the MV Hondius set sail in April, it was embarking on a “voyage of adventure to some of the world’s most remote islands”, said CNN. “Whales, dolphins and penguins awaited; landscapes of icy expanses, towering cliffs and rolling green hills beckoned.”

Now, the “nearly 150 passengers” are “isolating in their cabins, trapped aboard a ship anchored in the Atlantic, taking what measures they can to shield themselves from an outbreak of a deadly virus”.

Travel vlogger Kasem Hato, who is on board, said: “Most of the people on the ship are taking the matter very calmly.” The ship’s captain and staff are keeping passengers updated at regular intervals, while the passengers themselves are keeping “busy by reading, watching movies, drinking hot beverages”. He added: “If it were going to become an epidemic, it would have happened a long time ago.”

Crew and passengers are not only “trapped” on a ship experiencing a “lethal hantavirus outbreak”, but they are also “totally isolated from the rest of the world”, said The Times. Thought to cost around £10,000 per person, the cruise has “descended into something with tragic echoes of the early days of the Covid-19 epidemic”.

Whether the ship can dock in the Canary Islands has become a “hot political issue”, said the BBC. Fernando Clavijo, the islands’ president, has called his lack of involvement in the initial decision to permit docking there an act of “institutional disloyalty” by Spanish Prime Minister Pedro Sánchez. The head of the Island Council of Tenerife has announced her “outright and utter rejection” of the plan to allow the ship to dock in the territory.

A ‘miserable wait’

There are two possible ways passengers could have contracted hantavirus, said Thomas Jeffries of Western Sydney University on The Conversation. One is exposure while on a shore excursion, and the other is the possibility of rodents entering the ship in its cargo. “Hygiene standards and food storage practices may have caused the infection to spread more quickly.”

For investigators, the exact cause of the outbreak is a “mystery”, said The Telegraph. The Hondius “did not travel anywhere where the virus is endemic”, and Antarctic cruise ships have to adhere to “scrupulous infection control” to protect the environment. Passengers are “usually hosed down with disinfectant” before and after disembarking to avoid contaminating the area with any pathogens.

In the coming days, it may be possible to track down the source through the infected crew members, as they rarely accompany passengers on trips. “Narrowing down who went to particular locations should help pinpoint the source of the outbreak.” Unless a mouse or rat has “stowed away” on board, it is more likely that “several passengers on the ship were exposed at the same time, probably during an excursion”.

Thankfully, this is “not a new pandemic waiting to begin”, said The Telegraph. “The risk for the rest of the world is negligible.”

Having said that, isolating passengers are likely to “face a miserable wait”. Due to the incubation period of the virus, the ship may need to quarantine for up to eight weeks, and it’s likely the number of infections will rise. However, it is “unlikely to spread between passengers, so only those initially exposed will be at risk”.

What happened

Former New York City Mayor Rudy Giuliani is in critical condition in a Florida hospital as he recovers from pneumonia, but he “is now breathing on his own” after requiring a ventilator, spokesperson Ted Goodman said in a statement Monday. Giuliani, 81, is the “ultimate fighter” and “he is winning this battle.”

Who said what

Giuliani, once hailed as “America’s Mayor” for his response to the Sept. 11, 2001, attacks on New York City, has “struggled with legal and financial problems in recent years,” The New York Times said. Last year, he “suffered a fractured vertebra” from a car crash in New Hampshire, and he “made at least one public appearance in a wheelchair.” On his podcast last week, Giuliani said his voice was “a little under the weather.” Goodman said Giuliani had been diagnosed with restrictive airway disease stemming from his proximity to Ground Zero on 9/11, and “this condition adds complications to any respiratory illness.”

What next?

Giuliani’s health had “concerned those around him” recently, People said, citing a source close to the Trump administration. He “isn’t in good shape,” the source said.

The case of a woman denied sterilisation by the NHS has brought the procedure, and the alleged double standards that hamper access to it, back into the spotlight.

Leah Spasova, a psychologist from Oxford, spent 10 years trying to access the procedure, but her funding request was turned down over “concerns regarding potential regret and cost-effectiveness”, said the BBC. As the same NHS body regularly funds vasectomies without using potential regret as grounds for rejection, Spasova complained to the Parliamentary and Health Service Ombudsman.

Last Friday, the ombudsman ruled that a policy citing the “risk of regret” as grounds to refuse funding was “unfair” to women.

What did the ombudsman say?

The Buckinghamshire, Oxfordshire and Berkshire West Integrated Care Board’s approach was “unfair, inconsistent, and based on subjective reasoning”, the ombudsman ruled. And Spasova’s case “is not an isolated one”.

A committee responsible for recommendations across six integrated care boards in the southeast reviewed the female sterilisation policy after Spasova’s complaint. It recommended that regret or the availability of other contraception should no longer be used as grounds for refusal, and that all patients who meet the critiera can access female sterilisation.

“Rejecting my application for sterilisation on the basis of regret means they were taking on liability for my feelings,” said Spasova. Policies like this are “damaging for women’s healthcare” and “absolutely discriminatory”.

How does female sterilisation work?

Sterilisation is a procedure that blocks, seals or cuts the fallopian tubes, to prevent eggs from reaching the uterus. Also known as tubal ligation (“getting your tubes tied”), it’s usually performed under general anaesthetic via keyhole surgery, with about a week of recovery. Although complex procedures do exist to reverse it, they typically have a success rate of between 50-70% and aren’t usually available on the NHS.

Female sterilisation is the most common contraceptive method used worldwide, according to the UN. In 2019, nearly 24% of women using contraception relied on sterilisation – but it’s far more prevalent in Asia and Latin America than Europe.

A 2022 analysis of Dutch women puts the rate of regret at about 10.5%, compared with 5.1% of men who regret vasectomies. But the rate of regret is nearly twice as high among women under the age of 30: about 20%. NHS clinical guidance says sterilisation should be available for women, with counselling to address the risk of regret.

Is it available on the NHS?

Sterilisation for both men and women is organised by local integrated care boards (ICBs), as part of NHS contraception services. Most ICBs routinely fund both male and female procedures, subject to certain criteria being met, but some told The i Paper that “vasectomy is encouraged or preferred over female sterilisation”. Others “go one step further and restrict funding for female sterilisation”, said the paper. In those areas, women have to submit an individual funding request for approval.

In 2024-2025, the NHS carried out nearly 11,000 sterilisations: a year-on-year increase of 2%. But the long-term trend is downward: a 22% decrease in a decade. In contrast, the number of vasectomies performed in 2024-25 was 16% higher than in 2023-24.

What are the barriers to access?

Critics argue that the stricter eligibility criteria for women seeking sterilisation “amount to unequal treatment compared with men seeking vasectomies”, said The Guardian. But others say “tighter controls reflect legitimate medical concerns”, including the risks associated with a more invasive procedure.

Patients seeking sterilisation have been “told they are too young”, said Charlotte Glynn of the British Pregnancy Advisory Service. “There is a real problem with women not being trusted to make decisions about their own bodies,” she said. It is “a form of medical misogyny”, especially when many women "struggle with the side-effects of contraceptive pills”.

Many women are told they “might change their mind” or are asked what their partners think about their decision, Annabel Sowemimo, a consultant in sexual and reproductive health, told The i Paper. Tubal ligation also costs more than vasectomies as it requires “multiple members of staff and time in theatre”. This is compounded by the “obscene” waiting times for gynaecology treatment, she said. Life-threatening conditions are prioritised, while patients waiting for sterilisation are advised to use contraceptives instead.

Poor architecture can be a public health crisis. And in Tanzania, moving families into specially designed Star Homes has resulted in a marked reduction in the spread of deadly diseases among the children living in them.

Old vs. new housing

Most houses in Tanzanian villages use “mud and thatch” and are “single-story, placing the sleeping spaces at-grade,” said The Architect’s Newspaper. These living arrangements likely contribute to the spread of malaria, diarrhea and acute respiratory infections (ARIs), which are the “major causes of mortality in young children in sub-Saharan Africa,” said a study published in the journal Nature Medicine.

Designed by researchers, Star Homes are “novel double-story” houses that “provide an insect-proof, cleaner, cooler and smoke-free environment, with a reliable supply of water and sanitation,” said the study. They have “screened facades to allow airflow while keeping out insects, bedrooms on the top floor because mosquitoes mostly stay close to the ground, and an outdoor latrine and a system to harvest and store rainwater to help reduce the spread of diarrheal diseases,” said Science. They also have a “rodent-proof storage room, self-closing doors and a solar-powered electric light.”

To test the new housing, scientists randomly placed households with children under age 13  in either “110 Star Homes or in 513 traditional mud and thatched-roofed houses,” said the study. After 36 months, children living in Star Homes had a “significantly reduced risk of malaria (44% reduction), diarrhea (27%) and ARIs (18%) compared to children living in traditional mud and thatched-roof homes.”

The improved housing also led to a “reduction in stunting,” where children under age 5  were “taller for their age than those living in traditional homes,” said the study. Healthier children are the “ultimate measure of success,” said Salum Mshamu, the lead field investigator of the Tanzanian research consulting firm CSK Research Solutions, to The Architect’s Newspaper. “Reducing stunting has lifelong consequences for education, earnings and well-being.”

More for less

The findings show that “architecture can function as a health intervention on a par with medicine when it’s developed and documented using scientific methods,” said Jakob Knudsen, the lead architect of the Star Homes, to The Architect’s Newspaper. Traditional homes in Tanzania and other sub-Saharan countries tend to “absorb heat during the day and discharge it into the houses at night,” said The Architectural Review. “High interior temperatures lead to low use of bed nets (temperature rises further inside the net), increasing the risk of mosquito bites.”

The Star Home solves many of these problems and “costs 24% less in materials than a conventional single-story cement-block house, requires 73% less concrete and generates 57% less embodied carbon,” said a release about the study. “We now hope that the building industry will adopt some of the important features of our healthy house design,” said Steve Lindsay, a professor of biosciences at the U.K.’s Durham University and the author of the study, in the release. Better building practices can “turn a dangerous home into a safe one.”

What happened

President Donald Trump on Thursday tapped radiologist Dr. Nicole Saphier to be U.S. surgeon general, withdrawing the stalled nomination of nutrition influencer Dr. Casey Means, an ally of Health Secretary Robert Kennedy Jr. and the Make America Healthy Again movement. Saphier is Trump’s third nominee, after Means and Dr. Janette Nesheiwat.

Who said what

The “MAHA movement had pushed hard for Means’ nomination,” The Washington Post said, and it blamed its failure on Sen. Bill Cassidy (R-La.) and two other Republican senators skeptical of her qualifications and stance on vaccines. Trump called Saphier, a former Fox News contributor, an “INCREDIBLE COMMUNICATOR” on “complicated health issues” in a social media post. Kennedy called her a “longtime warrior for the MAHA movement.” But unlike Means, Saphier “does not appear to be a heroine” of MAHA, The New York Times said. Its “leaders view her as too conventional” due to her tempered praise of vaccines and criticism of Kennedy, though she has “also embraced” some of his agenda.

What next?

Even as MAHA lost its “favored influencer for surgeon general,” it “notched a big win on pesticide regulation” in a House farm bill, Axios said. Thursday’s events highlighted how MAHA retains “clout on matters related to the food supply” but “can be a political liability” on “vaccines and other public health matters.”

Along with wind, rain and lightning, the weather may bring about unexpected health problems. Acute attacks of “thunderstorm asthma” can worsen pollen allergies and exacerbate respiratory conditions. And as climate change is likely to cause more storms in the future, more people will be put at risk.

Storm surge

Generally, “rain tends to lower pollen counts by cleansing the air, and many people find that rainy weather tends to reduce asthma symptoms triggered by allergies,” said Harvard Health Publishing. But thunderstorms are an exception because they can cause cold downdrafts, which “concentrate air particles, such as pollen and mold.” The particles are then “swept up into clouds where humidity is high,” and “wind, humidity and lightning break up the particles to a size that can readily enter the nose, sinuses and lungs.” Strong gusts of wind disperse the pollen and mold, irritating lungs.

The rapid breakdown and spread of air particles can cause thunderstorm asthma. “Right after a thunderstorm, people can have more asthma,” Clifford Bassett, the founder and medical director at Allergy and Asthma Care of New York, said to The Weather Channel. The phenomenon is caused by a “complex interaction between environmental and meteorological factors, coupled with intense aeroallergen exposure in susceptible individuals,” Constance H. Katelaris, a senior staff specialist of immunology and allergy at Campbelltown Hospital and Western Sydney University, said at InSight+.

Those most likely to experience thunderstorm asthma are people with pollen allergies and hay fever (rhinitis), as well as those with preexisting asthma and poor asthma control. Adults in their third or fourth decade of life appear to be especially susceptible. Older children are also vulnerable, being in the “peak ages for expression of allergic rhinitis,” said Katelaris. There may also be a “significantly increased risk among individuals of Asian and Indian descent,” according to data from the “largest and deadliest episode of thunderstorm asthma recorded to date,” in Melbourne in 2016. “Six of the 10 people who died were of Asian or Indian descent.”

A big storm’s a-coming

While thunderstorm asthma “may seem like more of a curiosity than a serious threat to public health,” when it “affects a large population area, emergency rooms can become overwhelmed,” said Harvard Health Publishing. During the Melbourne episode, over 3,400 people experienced severe asthma symptoms and 10 people died. “Any pollen, any dust, anything that is sitting on the ground will be dispersed, and it will be blown onto cars, into the circulating air, perhaps into homes, if the windows are open, and onto anyone who is outside and unfortunate to be in the path,” meteorologist Dante Ricci said to National Geographic.

Cases of thunderstorm asthma are expected to increase in the future due to climate change. Globally warming temperatures can lead to “prolonged allergenic pollen seasons combined with increased pollen allergenicity, as well as heightened likelihood of extreme weather events,” said a review published in The Journal of Allergy and Clinical Immunology: In Practice. In the U.S., “more than 28 million people have asthma and about 81 million people have seasonal allergies,” said Harvard Health Publishing. The best way to prevent thunderstorm asthma is to have rescue inhalers and medicine handy and to avoid going outside for 24 hours after a storm if you experience pollen allergies or preexisting asthma.

“Having an older sibling can be a mixed blessing,” said The Times. You have a “ready-made playmate”, but younger siblings must endure hand-me-downs, while sharing toys and the attention of their parents.

But a new study shows that birth order could also affect the likelihood of developing certain conditions. Research led by the University of Chicago has analysed data from more than 10 million siblings in the largest ever study of its kind. It found associations between the order of birth and susceptibility to autism, anxiety, hay fever and migraines, among other health conditions.

Though the findings should not be read deterministically, and have not yet been peer-reviewed, more than a third of medical conditions (150 out of 418) showed “birth order associations”, according to the study. “Of these, 79 were more common in firstborns, while 71 were more common in those born second,” said New Scientist.

What it shows

Previous studies have been criticised for “cherry-picking data or failing to control for confounding factors”. And more research has been done on the links between birth order and IQ. For example, a “landmark” study in 2015 analysed data on 20,000 children and found that birth order had “almost no bearing on personality and only a small association with IQ”. It recorded a “drop of about 1 to 2.5 IQ points between oldest and youngest siblings”.

The latest study, however, focused on the “likelihood of developing different conditions”, said New Scientist. In order to “mitigate some confounding factors”, such as the “influence of how parents might treat their first and second children differently”, researchers first compared 1.6 million pairs of siblings by “coupling firstborns from one family with those born second from another family”. They were matched on sex, birth year, parental age and sibling age gap.

The study analysed more than 10 million individuals from more than five million families, and found that elder siblings were more likely to be diagnosed with “neurodevelopmental conditions”, such as autism, ADHD and allergies, as well as acne and childhood psychoses, said Scientific American. Second-born siblings, on the other hand, were more likely to be diagnosed with “substance use disorders, shingles and gastrointestinal disorders”.

How far siblings are born apart also “appears to matter”. If the age gap was less than four years, siblings were associated with a lower rate of asthma and other allergies. This aligns with the “hygiene hypothesis”, which suggests that “lower exposure to allergens in early life” can lead to them overreacting to allergens later.

Strengths and limitations

“Overall, this seems like a really rigorous study,” Rohrer told New Scientist, though the associations are modest. Additionally, “we will only observe every person in one birth-order position” and “never know how their life would have played out differently in another position”.

The study’s “strength” is in its “large sample size and design”, which allowed cross-comparison between different families to “control for socioeconomic status and genetics”, said Scientific American.

However, a limitation was that researchers used “administrative insurance claims data” instead of “reviewing the prevalence of health conditions”. Parents could be more likely to seek diagnoses for their firstborn than any subsequent children. “You can’t get a diagnosis if you don’t seek it,” said Rodica Damian of the University of Houston, who was not involved in the study.

Though the variations between siblings identified in the study are small, “they can have an effect” at the “population level”. As Rohrer said: “It could be that all of these small effects of birth order come together to make a difference.”

There has been an increase in the spread of alpha-gal syndrome (AGS), a tick-borne disease that can cause a serious allergy to red meat. More than 110,000 suspected cases of AGS were identified between 2010 and 2022, and while the actual number of U.S. cases is not known, as many as 450,000 people may be affected, according to the CDC. With a particularly strong tick season on the horizon and climate change continuing to worsen, the illness is likely to become more common.

What are the symptoms of AGS?

Alpha-gal is a molecule that is “naturally produced in the bodies of most mammals but not in people” and also “found in the saliva (spit) of some ticks,” said the CDC. When someone gets bitten by a tick, the alpha-gal molecule can be transferred to their blood. Then the “body’s natural defenses, or immune system, can identify alpha-gal as a threat and trigger an allergic reaction.” The reaction occurs “after people eat red meat or are exposed to other products made from mammals.”

Unlike most other allergies, which tend to produce reactions almost immediately, “those with alpha-gal may not experience a reaction to a hamburger for four or six hours” because of “how alpha-gal binds to fats, taking longer to absorb,” said The New York Times. Symptoms may manifest in different ways depending on the person, including “hives, angioedema, gastrointestinal distress and life-threatening anaphylaxis,” said an article published in the Journal of Medical Entomology. There is currently no cure for AGS, and the most common treatment is avoiding “not only red meat and dairy but also vaccines, antivenoms and medications made with components derived from mammals,” said Entomology Today.

AGS can be diagnosed through a blood test, but experts advise getting tested only when someone experiences a reaction and not just after being bitten by a tick. “It’s perfectly clear that 50% of people who have a positive test have no reactions whatsoever,” Thomas Platts-Mills, an allergist at the University of Virginia School of Medicine, said to the Times. The factors that determine whether someone has a reaction are still unknown. Along with some people being asymptomatic, “there are so many false positives,” Scott Commins, a professor at the University of North Carolina at Chapel Hill School of Medicine, said to the Times. “So testing after any tick bite would lead to a lot of people avoiding red meat unnecessarily.”

How common is it?

It will likely be a bad year for ticks, “with an unusually high number of bites already reported across the country,” said The Associated Press. “If you have a lot of exposures, there will probably be more cases of tick-related infections,” Alina Filozov, an infectious disease doctor at Middlesex Hospital in Middletown, Connecticut, told the outlet. In the U.S., AGS is “primarily associated with the bite of a lone star tick” and less commonly with the bite of a “blacklegged tick or a western blacklegged tick,” said the CDC. There have been at least 12 tick species linked to alpha-gal syndrome globally, and the disease has been found on six continents.

The best way to prevent AGS is to avoid being bitten by ticks in the first place. Steer clear of heavily wooded or grassy areas, wear light colors and use an approved insect repellent. If you do find a tick on yourself or your pet, remove it immediately.

Climate change is expanding the range of these insects. “Ticks like warm, humid weather, and more can be seen after a mild winter,” said the AP. “More deer and mice available for them to feed on may also factor.” Along with AGS, ticks can spread other diseases, including Lyme disease and Rocky Mountain spotted fever.

People have long sought drug-assisted therapy. Now, rumors of certain drugs helping to treat or even heal mental health disorders has led to a surge in psychedelic retreats. These trendy respites operate overseas in countries like Jamaica and Peru; they also exist in the U.S., albeit with legal gray areas. But safety concerns have cropped up following a recent study.

Dubious precautions

Mounting interest in the potential benefits of psychedelic drugs has led to a rise in psychedelic retreats around the world. Such places offer multiday trips where attendees “pay for drug-assisted experiences” and are promised “psychological healing” and “personal growth,” said The Associated Press. Nearly all of the drugs typically offered at these retreats are “illegal under U.S. federal law,” including “magic mushrooms, ayahuasca, MDMA and LSD.” But retreat companies don’t always “make that explicit.” Sometimes they claim they are “protected by a rare legal exemption for religious organizations that traditionally use psychedelics.”

The “hard line between clinical intervention and all other uses” of drugs, such as spiritual and recreational, has blurred, said Hadas Alterman, a psychedelic medicine attorney, to Fox News. Psychedelics now “serve people who aren’t in crisis but aren’t merely thrill-seeking either.”

Many retreats have safety protocols in place, but they still carry the risk for “physical, psychological and interpersonal harms,” said researchers in a paper published in JAMA Network Open. It is therefore important that anyone interested in a psychedelic retreat “do their research” and “talk to the organizers or facilitators to get more information about what is being offered and how,” said Amy McGuire, a biomedical ethicist and co-author on the study.

The study, which surveyed dozens of retreats, documented a wide range of concerning practices, including “companies offering multiple psychedelic drugs,” said the AP. Many retreats have health professionals on site, but “their roles and responsibilities are often vague.” In some cases, they “take psychedelics alongside participants,” which could impair the professionals’ “ability to respond in an emergency.” Almost 90% of the surveyed retreats additionally “require or recommend that attendees stop taking certain medications,” including antidepressants, before using psychedelics. These “washout periods” ranged from “one day to six weeks before the psychedelic experience.”

Regulatory changes on the horizon

While psychedelics are not federally approved in the U.S., that may soon change. President Donald Trump last week signed an executive order directing the Food and Drug Administration to “accelerate reviews of psychedelics that show potential for conditions like post-traumatic stress disorder,” said the AP. The order also directs “law enforcement agencies to quickly lower restrictions on any psychedelic approved by the FDA.”

Due to the state-level decriminalization of psilocybin, Oregon and Colorado have become psychedelic retreat hubs for what some call “transformative travel,” said Parade. Relying on state regulation is risky because “each one is going to be slightly different,” Albert Garcia-Romeu, the associate director of the Center for Psychedelic and Consciousness Research at Johns Hopkins University, said to The Guardian. It would make more sense to go the “FDA-approved medication route” because that comes with a “set of authoritative guidelines from major medical and regulatory bodies.”

People in the field say today’s retreats are safer than they have been in past decades, when “psychedelic experiences were almost always conducted underground with few safety precautions,” said the AP. The growing market for psychedelics has also “allowed retreats to expand their services, hire more medical and coaching staff and take safety more seriously than we’ve ever seen in the past,” said Brad Burge, who has worked with psychedelic nonprofits, drugmakers and retreat operators, to the outlet.

Still, there are no “industrywide standards or regulations for how participants are screened, prepared or monitored afterward,” said the AP. So “what does that mean about the quality of care you’re going to have?” said Joshua White, the founder of the Fireside Project, which runs a hotline for people experiencing distress during psychedelic trips, to the outlet. Without regulation, there could be a “race to the bottom where there is no liability or accountability.”

We tend to think of our medieval ancestors as warty, unwashed, riddled with fleas, doomed to die young, and with little or no knowledge of medicine, or the body’s workings, said Helen Carr in The Telegraph. But in this “richly” detailed book, Katherine Harvey seeks to explain what they did, thought and knew – and it turns out that many of their concerns mirrored our own, from digestion and hair loss to mental health. Their medicine was based on the idea that the body was made up of four “humors” – blood, phlegm, black bile and yellow bile – connected to air, fire, earth and water. Good health relied on keeping them in balance, by blood-letting for example.

Medieval physicians’ views on diet, said Gerard DeGroot in The Times, were surprisingly similar to ours; they recognised the importance of fresh air and clean water, and they perceived a connection between body and mind. During the plague in Venice in 1348, “restrictions were placed on the wearing of mourning garb because it encouraged sadness, which damaged physical health”.

That said, some of their treatments were pretty weird. A mix of cow dung and wine was thought to cure obesity; male baldness was linked to the body drying out, so baths were prescribed. As for sex, this was believed to be good in moderation – for marital harmony, and as a form of exercise. If both parties orgasmed, all the better as this would help in the excretion of harmful superfluities.

This is a terrific book: I’ve rarely had such fun learning about the past. Ultimately, it leads one to the conclusion that our ancestors were “a lot like us: they fretted about their health, took steps to improve it, and cared for those who suffered. In the process of examining the medieval body, we also get a glimpse at the soul.”

Rotavirus, a potentially deadly gastrointestinal pathogen, is being transmitted at an alarming rate across the country. Young children are the most at risk of severe infection. Experts believe that reduced vaccination rates are behind the trend.

How bad is rotavirus?

Every year, rotavirus is “responsible for 20 to 60 deaths in the U.S., more than 400,000 doctor visits, more than 200,000 emergency room visits and between 55,000 and 70,000 hospitalizations among children under 5,” said Newsweek. Infection rates are higher now than they were at the same time last year, according to CDC data. The percentage of positive rotavirus tests across the country has been steadily increasing since January. “We’re seeing a lot of rotavirus in wastewater right now,” which indicates that “there are high levels of infections in these communities,” Marlene Wolfe, the program director of WastewaterScan, said to NBC News.

Rotavirus can cause gastroenteritis with a “fever above 101 degrees Fahrenheit and vomiting for one to two days, followed by frequent diarrhea,” said Discover Magazine. While “anyone can get infected, the virus spreads particularly quickly among babies and young children via the fecal-oral route through contaminated hands and surfaces.” The virus can lead to severe dehydration, which may require hospitalization. At its peak, there can be “upwards of 20-plus episodes” of diarrhea per day, Stephanie DeLeon, the associate chief medical officer and a pediatric hospitalist at Oklahoma Children’s OU Health, said to NBC News. In the worst cases, the virus is deadly, especially among younger children.

As with most viruses, there is no specific treatment once someone develops gastroenteritis from rotavirus. Doctors “only provide supportive therapy,” including “hydration such as electrolyte drinks or IV fluids in the case of dehydration, small and frequent feeding as well as fever control with medications like Tylenol,” said Forbes. Usually, the symptoms resolve in approximately a week.

Why is it spreading?

Some of the surge in infection is because rotavirus “follows a fairly regular annual pattern, much like influenza,” Ben Lopman, a professor of epidemiology at Emory University, said to Newsweek. “What’s driving this year’s surge is the same basic biology it always has been: A highly contagious virus circulating through communities where young children are in close contact.” The disease tends to peak in late winter and early spring and decline in the summer.

While there is no treatment for rotavirus after infection, the disease can be prevented. There are two different oral vaccinations available against the pathogen. Given during infancy, “7 out of 10 children who get the vaccine will be protected from getting infected, and 9 out of 10 will be protected against severe disease,” said Forbes. Unfortunately, “doctors have fresh concerns that declining vaccinations could lead to more severe illness and a higher surge in the coming years,” said NBC News. Most of those infected and hospitalized are “either too young to get the vaccine, haven’t received all the doses yet or are unvaccinated.”

Vaccine hesitancy may have made this year’s surge worse. Parents refusing to vaccinate their children has also increased cases of diseases like measles and whooping cough. “As someone working on this virus for more than a decade, I ultimately want rotavirus to become less relevant over time, with continued reductions in severe disease and mortality,” Siyuan Ding, a professor of molecular microbiology at the Washington University School of Medicine in St. Louis, said to Newsweek. “It is therefore concerning to see case numbers trending upward this year.”

“A little blue pill is creating a stir in Hollywood,” said Dipa Kamdar, senior lecturer in pharmacy practice at Kingston University, London, on The Conversation. “And no, it’s not Viagra.”

For several years now, celebrities have been singing the praises of propranolol, a beta-blocker originally designed for heart conditions which also helps with anxiety. Kristen Bell, Rachel Sennott and Natasha Rothwell have all mentioned taking the pill at red-carpet events over the past year. Four years ago, Khloé Kardashian admitted she borrows her mother’s medication to calm her nerves, while Robert Downey Jr started his 2024 Golden Globe acceptance speech by saying he had just taken a beta-blocker “so this will be a breeze”.

These A-lister endorsements have led, in part, to a surge in prescriptions, especially among young women and girls, with propranolol now the “go-to pill for dealing with all sorts of stressful situations, from public speaking to first dates”, said The Wall Street Journal.

How does it work?

The beta-blocker was approved by the US Food and Drug Administration in 1967 for the treatment of heart problems including high blood pressure, arrhythmia (irregular heart rate) and angina. But it soon became clear the drug also reduced physical responses to anxiety, such as high heart rate, sweating, nausea and trembling hands. And while other medications prescribed for anxiety, like certain anti-depressants, can take weeks to work, propranolol can take effect within an hour.

Unlike drugs like Xanax or Valium, which “act directly on the brain and can leave people feeling sedated, foggy, or zoned out”, propranolol doesn’t address anxiety’s “underlying roots” but “blocks its physical symptoms” by slowing down the heart rate and lowering blood pressure, said The Boston Globe.

“It’s a beta-blocker, not a bravery booster”, said Kamdar. “It won’t fix your fear of public speaking or make you smoother on a first date – though it might stop your hands from shaking while you try.”

How widely is it used?

In the US, overall prescriptions are up 28% from 2020, while NHS England figures show an increase of 37.6% over the past decade, according to data seen by The Observer. The biggest rise in the UK has been among girls aged between 12 and 17 – up from 618,813 prescriptions in 2015 to more than 1.1 million in 2025. The second highest increase in use – at 81.7% – is among women aged 18 to 23.

The increasing popularity of beta-blockers among young women and girls “points to a generation that has grown up with the pressures of social media and an epidemic of gender-based violence, as well as the isolating effects of Covid”, said the outlet.

As well as its speed and availability, its appeal may also lie in the fact that, unlike other mental health medication, “culturally” propranolol is “portrayed lightly – as if it’s nothing more than a breath mint”, said The Boston Globe.

Are there any risks?

Compared to Xanax or Valium, propranolol is a non-addictive and low-risk medication. However, “it’s not without risks or side-effects”, said Kamdar on The Conversation. Because propranolol works to reduce blood pressure and heart rate, common side-effects include dizziness, fatigue, cold hands and feet, and vivid dreams. “More serious risks – though rare – include heart failure, breathing difficulties and allergic reactions”.

In the UK, where propranolol is licensed to treat anxiety, its effects have been “more scrutinised”, said the WSJ. The General Pharmaceutical Council has highlighted the risk of overdose following the death of a 17-year-old girl in 2023, who died after taking propranolol along with other pain-relief medication. The UK’s National Institute for Health and Care Excellence anxiety-management guidelines recommend cognitive behavioural therapy, mindfulness and antidepressants as initial treatments.

“It wasn’t long ago that crunchy or smooth was the sum total of our nut butter options,” said Sue Quinn in The Telegraph. But there is now more choice than ever and the “humble peanut is jostling for shelf space with almond, cashew and pistachio” spreads.

Sales of peanut butter overtook jam in the UK for the first time in 2020, and nut butters are “now making a bid to unseat honey from its long-held perch as number one”.

Filled with “fibre and healthy fats, it’s easy to see why nut butters appeal to the health-conscious among us,” said Lauren Shirreff in The Telegraph. They are a fantastic source of protein, “especially for people who are following plant-based or vegan diets”, nutritionist Jenna Hope told the paper.

A 30g serving of peanut butter contains around 8g of protein, which is “roughly the same as that in a large egg”, and a large spoonful “would also contain nearly three whole grams of fibre”.

One of the best alternatives to peanuts is almond butter, said Shirreff. It ticks lots of boxes, having the “most fibre” of any nut butter, and “fewer calories” too. Though it has “marginally” less protein than peanut butter, it’s “packed with magnesium and calcium”.

Pistachios have been all the rage as TikTok-viral sweet treats – think Dubai chocolate – but the best way to unlock their “bold, subtly sweet, roasted-nutty taste” is in savoury dishes, said Autumn Swiers on Tasting Table. A dollop of pistachio butter can be “placed under the skin of a chicken breast pre-roast for extra crispy, sweet-nutty moisture”, or as an “elevated candidate for homemade salad dressings”.

It is important to check the label for additional ingredients, said nutritionist Brianna Sommer on Delish. “I would look for a pure nut butter that has no added anything.” It is much better to add a pinch of salt, or a dollop of honey yourself than relying on whatever the “manufacturer has decided to include”.

The easiest way to eat nut butters is “on a slice of sourdough” or “poured over porridge”, said Stacey Smith in Women’s Health. But we all know they taste just that bit better “sneakily spooned straight from the jar”. For a “treat day” indulgence try Pana Organic Cashew Caramel Spread. “Packed with good stuff”, it includes coconut sugar for a hint of sweetness, while maca and sesame seeds bring “extra oomph”.

And if you’re looking for a classic peanut butter, try the M&S range, said Martha Roberts on Which?. Its smooth version is “rich”, “creamy” and “high-oleic” with the highest fibre content of the 56 items tested. Not only is it "reasonably priced”, it contains high levels of protein, and is “extremely low” in salt. Its crunchy alternative “comes a close second to its smooth sibling” because of its higher calorie and lower fibre content, but it’s “still high-oleic and with the same keen price”.

The internet is rife with trends promising to optimize your body, and right now, peptides are the It drug. Available as injectables, intravenous infusions, pills and nasal sprays, the chains of amino acids are rumored to help with weight loss, anti-aging and rapid muscle repair. But government restrictions have led to an increase in gray-market sales of peptides — something its champions hope to change soon.

New wonder drug?

The human body naturally produces peptides. They have fewer amino acids than larger proteins and are responsible for sending messages or regulating the body’s systems. Researchers have known about some peptides for decades, and “dozens have been turned into safe and effective drugs,” said The New Yorker. The hormone insulin, for example, is a peptide that “moves sugar from the bloodstream into cells” and is used to treat diabetes.

The drugs that are driving the current wellness trend are part of a broad category of synthetic short-chain amino acids that includes “familiar, well-studied items like insulin and GLP-1 weight loss drugs,” said Stat News. Unlike those two FDA-approved uses, however, the peptides being touted by some influential figures in the health sphere are part of a “thicket of newer drugs with catchy names like BPC-157, TB-500 and CJC-1295.” Most of them have “comparatively little research” to support claims that they can “treat injuries and chronic pain, increase muscle, slow down the aging process and boost energy.”

Off-label use of peptides was initially popular among bodybuilders. Still, in the “era of Make America Healthy Again,” their popularity has risen among the general public, said The New Yorker. Compounding pharmacies are experiencing soaring demand, and imports of gray-market peptides and hormones from China nearly doubled last year, The New York Times said. Influencers like looksmaxxer Clavicular and podcaster Joe Rogan, as well as Health Secretary Robert. F. Kennedy Jr., are among those singing their praises.

Part of the appeal of peptides is the “promise of autonomy,” Stat News said. The idea is that if you “take the right blend of drugs, along with good nutrition and exercise,” it’s “possible to DIY your way into optimal health.” This coincides with the “right-to-try” philosophy touted by physician Gabrielle Lyon on celebrity fitness trainer Jillian Michaels’ Keeping It Real podcast last year. People should “have physical autonomy,” Lyon said during a discussion about peptides, and as long as it doesn’t hurt them, “they should be able to choose.”

Kennedy comes for the gray market

In 2023, during Biden’s administration, the FDA placed 14 peptides on a “do not compound” list due to “potential significant safety risks,” which included immune reactions, pancreatitis and accelerated growth of cancerous cells. In February, Kennedy said the FDA would make changes to make their use more acceptable. “I’m a big fan of peptides,” Kennedy said on The Joe Rogan Experience podcast, adding that he “used them myself to really good effect on a couple of injuries.”

A senior Health Department official said the FDA plans to “aggressively enforce rules against making false or misleading claims about medical benefits” while moving forward in allowing compounding pharmacies to produce the injectable peptides, said the Times. The agency is also planning to convene its Pharmacy Compounding Advisory Committee. That group is likely to “consider whether there is a medical justification for the peptides” and vote on adding them to a list of products that compounding pharmacies can legally use.

Lifting the restrictions on peptides would be done in an effort to curtail the use of “very substandard” gray-market products, Kennedy said to Rogan. He wants people to have access to “ethical suppliers.” However, such logic could set a dangerous precedent. If you “applied that argument more generally,” it would “prevent the government from banning almost any substance that people widely demand,” said Lewis Grossman, a professor and the author of “Choose Your Medicine: Freedom of Therapeutic Choice in America,” to Stat News.

Proponents of the peptide movement remain unmoved. Critics will say, “if the FDA were to do this, this will create the Wild West,” Brigham Buhler, a compounding pharmacy owner, said to the Times. “And my rebuttal to that is: We are living in the Wild West.”

In shops, offices and bars across Spain, a single story has been monopolising conversation, said Enrique Aparicio in El Público (Madrid). The case of 25-year-old Noelia Castillo, whose life was ended by euthanasia in a Barcelona hospital last month, has “stirred the entire country”, sparking a fierce debate about an assisted-dying law introduced in 2021.

Castillo had had a troubled life; she'd spent her teen years in state-run foster care, had suffered several sexual assaults, and in 2022 was gang raped by three men. Days after that, she threw herself out of a fifth-floor window. The suicide attempt left her paralysed and in chronic pain with depression: insisting that her life was no longer worth living, she asked that it be ended. However her father, backed by a religious advocacy group called Christian Lawyers, claimed that given her fragile mental state, she was in no position to give meaningful consent to an assisted death.

‘Unnecessary suffering’

It's appalling the way in which Castillo was denied the right to a dignified death, said El País (Madrid). Her euthanasia had been unanimously approved, as the law requires, by two doctors, a lawyer and a review and oversight body; and it had been scheduled to take place on 2 August 2024. But then the legal challenges started to roll in, and it was only on 10 March this year, when the European Court of Human Rights rejected the final appeal by Christian Lawyers, that they came to an end. And so her “unnecessary suffering” was prolonged for a “devastating” 601 days, and in the full glare of media attention.

No, that puts everything the wrong way round, said Javier Redondo in El Mundo (Madrid). The assisted-dying law was supposed to provide a “dignified death” for terminally ill patients languishing “bedridden, paralysed and intubated; in agony”. It was not meant for young people like Castillo, who “lacked hope for the life ahead”. This case has fundamentally shifted the “boundaries of euthanasia”.

‘Abandoned’ by society

Indeed, the noise of this scandal should reverberate “far beyond the borders of Spain”, said Laurent Frémont in Le Figaro (Paris). It lays bare a society that no longer knows how to look after its most needy citizens. At every turn, Castillo was failed by the state: it took her from her family when she was a teenager and put her in foster care; she was still in the state's care when she was gang raped; and finally, instead of providing the psychiatric care she so badly needed, the state granted her a medically assisted death. In short, she was “abandoned by the institution” meant to take her family's place.

We need to be careful here, said Pedro García Cuartango on ABC (Madrid). I myself am morally opposed to euthanasia, and I too view Noelia Castillo's death as a societal failure. Yet we must acknowledge that the assisted-dying law was passed by an absolute majority in parliament and thus has full political legitimacy. We may hate the outcome, but in the clash between the law and our moral convictions, we in the end have to accept the law.

Several thousand people have been killed in Iran since the U.S.-Israeli war broke out, and the conflict has created an additional humanitarian crisis: delays and shortages of medical supplies. Hospitals and health care clinics throughout the Middle East are reporting critical lapses in supplies, which experts fear could lead to a surge in deaths even as the U.S. agreed to a temporary ceasefire.

What did the commentators say?

With the war in a state of flux, humanitarian centers “across the Middle East, Asia and Africa are facing the risk of running out of basic medication and food” due to the “restriction of shipments in the Strait of Hormuz,” said NPR. Some of this food, especially dry and canned goods, can “be stored for a long time,” Bob Kitchen, the vice president of emergencies and humanitarian action with the International Rescue Committee, said to NPR. But health care supplies are a different story, as most of the “medicines or treatments for malnutrition will expire.”

Many of these countries rely almost entirely on foreign aid for medical supplies. Sudan, for example, has “no manufacturing capacity and is entirely dependent on imported medication,” Omer Sharfy of Save the Children in Sudan said to NPR. This means health care workers “won’t be able to find alternatives in the local market.” The war has also “disrupted the movement of medical supplies from WHO’s global logistics hub in Dubai,” said the World Health Organization. By March 11, just 12 days into the war, over “50 emergency supply requests, intended to benefit over 1.5 million people across 25 countries,” were “affected, resulting in significant backlogs.”

Even countries far away from the conflict are bearing the brunt of these scarcities. Fears of syringe and IV shortages in South Korea are “spreading through Korea’s health care sector, prompting authorities to urge medical providers to refrain from stockpiling,” said The Korea Times. The problem is not that the Persian Gulf countries are “major drug producers. They’re not,” said health care news nonprofit Healthbeat. But these nations do “form ‘a critical pharmaceutical transit hub,’ where drugs and their basic ingredients from India, Europe and China routinely pass before heading to Africa, Asia and the United States.”

What next?

Some are hopeful that the two-week ceasefire, announced by President Donald Trump and initially agreed to by Iran, will allow the flow of medicine to restart. But while the U.S. has backed a ceasefire, Israel has continued its assault on the region, carrying out a series of strikes in Lebanon. Iran reclosed the strait in “response to Israeli attacks against the Hezbollah militant group,” said The Associated Press. Iran later accused the U.S. of also violating the deal and claimed that a long-term ceasefire was “unreasonable.”

Even before the strait was closed again, experts say it is unlikely its opening would have made a huge difference in moving global medical supplies. The ceasefire deal would not lead to a “‘mass exodus’ of ships through the Strait of Hormuz,” said The Guardian. The deal also allows Iran and Oman to “charge a fee of up to $2 million a ship on vessels transiting through the strait,” which could further limit the amount of supplies that are able to pass.

With no end to the larger skirmish in sight, fears persist that the shipment of medical supplies could remain at risk. All of these events are happening in an industry that was “decimated by funding cuts from the United States and Europe last year,” said The Washington Post, and is “now straining to meet demand that grows with each additional day of war.”

A new dating service has sprung up in Japan, aiming to get around the country’s ban on married couples having different surnames.

In a series of match-making events held this spring, every participant shared the same family name. The concept, the organisers said, is simply that “two people who already have the same last name won’t have to agonise over which one to use after marriage”.

Are you a Sato, Suzuki, Tanaka or Ito?

Japan’s current civil code, which dates back to the 19th century, specifies that a husband and wife must use the same family name. While there is no stipulation which name the couple adopts, in the country’s male-dominated society it is the man’s in 95% of cases. While critics claim this affects women’s employment prospects and contributes to Japan’s low birth rate, conservatives maintain that any change would undermine the traditional family unit and cause confusion among children.

Either way, it leaves young couples with an added pressure when trying to find a life partner. Four in-person gatherings in Tokyo, each focusing on one of Japan’s most popular surnames – Suzuki, Tanaka, Sato or Ito – “offer a rare opportunity for people who share a surname to meet someone they could legally marry without either person having to change names”, said news site The Mainichi.

It is not hard to see the appeal. A recent survey conducted by Asuniwa, a Tokyo-based association that advocates for a selective separate surname system and co-organises the events, and dating app Pairs, polled 2,500 people in their 20s and 30s. They found 36% of women and 46% of men “felt resistance” about changing their surname, while a smaller proportion had misgivings about their partner changing their name. Around 7% said they would break up if neither partner wanted to change their surname, while just under 6% said they would “wait until the (separate surname) system is legalised” to tie the knot.

“I hadn’t given much thought to the idea of marrying another Suzuki, but I can see now why it’s a safe option,” Taisho (not his real name) Suzuki, a 33-year-old company employee, told The Guardian. “I don’t want to give up my surname when I marry, and I know a lot of women feel the same about their names.”

For others it is more of a novelty. “To be honest, I’m not too fussed about keeping my maiden name, but I thought it would be fun to meet another Suzuki,” said Hana (not her real name) Suzuki, a 34-year-old nurse.

‘Bump in the app before you bump in bed’

For would-be couples in Iceland, the problem is being related to your partner. With a population of just 330,000, the risk of pairing up with someone genetically similar to you is high.

“Now, as social media and apps expand the dating pool”, many people are turning to a website “to ensure they aren’t swimming in the same gene pool,” said The Wall Street Journal.

Tracing a person’s lineage in Iceland is “especially challenging because last names are no indicator of historic family lineage”. Usually, a person’s last name is the father’s first name, followed by “son” or “dottir”.

“Íslendingabók”, or the Book of Icelanders, is an online database that contains the full genealogy of 720,000 Icelanders, living and deceased. While the historical work dating from the 12th century was not originally designed for dating, it led to a spin-off app that allows users to bump their phones together to instantly trace whether their family trees are intertwined, sparking the tagline “bump in the app before you bump in bed”.

China’s parent trap

In China, meanwhile, some parents are taking matters into their own hands to find partners for their children.

There is a long tradition of in-person outdoor “marriage markets”, where parents display handwritten CVs of their unmarried children in the hope of finding suitable partners.

Many are now “increasingly turning to ‘find a daughter-in-law’ or ‘find a son-in-law’ platforms online, turning partner-seeking into direct negotiations between parents”, said South China Morning Post.

“Instead of trying to persuade single young adults who resist matchmaking”, a few “sharp-eyed businesses” are now “directly targeting a different demographic: anxious parents with strong purchasing power”.

Quarterly membership costs 399 yuan (£43), for an online profile with an individual’s age, education, occupation and income, as well as home ownership status and expected timeline for marriage, prioritised above personality traits, hobbies, and interests.

A new injectable filler is making a splash for being minimally invasive and for the source that fills its vials: donated human fat from cadavers. The eerie origins of the shots have led to a mixed response. Some praise the innovations; others worry about future complications.

The rise of ‘corpse cosmetics’

Tiger Aesthetics’ new product, AlloClae, has become popular with “patients eager to look their best in the boardroom” without “undergoing general anesthesia or taking days off for recovery,” said Business Insider. Rather than using an implant or a patient’s body fat to add volume to hips or augment breasts, AlloClae relies on “donor fat from a cadaver as a first-of-its-kind body filler.”

While the procedure could cost as much as $100,000, people are “paying for the convenience,” cosmetic surgeon Sachin Shridharani said to Business Insider. It is about “not having the downtime, not needing more aggressive procedures, not having an anesthetic.” On social media, influencers sometimes refer to buttocks injections of AlloClae as ‘zombie BBLs,’ ‘zombie filler’ and ‘corpse cosmetics.’

The rise in GLP-1 use has contributed to the trend, along with “filler fatigue,” as traditional fillers can “cause problems such as puffiness and lymphatic issues,” said The Guardian’s Ask Ugly column. People who are on Ozempic or are dieting heavily are “really thin and don’t have enough fat to transfer,” plastic surgeon Melissa Doft said. They want their “legs and their belly to be skinny but want their breasts to be fuller.”

Even though AlloClae comes from cadavers, the product is “less macabre than you may think,” said Business Insider. Tiger Aesthetics purchases abdominal fat cells from organ donations at tissue banks. Then the company “screens it for diseases, purifies it and processes it.” The practice of using cadaver material is not unprecedented. There is already a donor fat product called Renuva, used for facial injections, while AlloClae uses higher volumes for the body. Cadaveric bones have also been recycled in dental grafts. Cadaver tissue, known as “allografts,” is “commonly used in surgically treating ACL tears,” said The Guardian.

Concern brews among surgeons

While a select few plastic surgeons have begun offering AlloClae injections, others have concerns, “especially when it comes to using AlloClae in the breast,” said The Cut. Breast is not “just fat, it’s glandular, hormonally active and requires lifelong imaging for cancer screening,” said plastic surgeon Adam Kolker. Anything injected can “create new densities, nodulifications or cysts,” which can “complicate mammography and ultrasound.” Without imaging and safety studies, physicians can’t responsibly predict how AlloClae will “behave during cancer surveillance.” A new “biologic material with unknown imaging behavior” becomes a “big diagnostic question mark.”

AlloClae is a “good tool,” said surgeon Glenn Lyle to The Guardian, but there is wariness about how eagerly people are adopting it. The industry is “moving too fast with this” without “follow-up studies.” The product is “being put in willy-nilly.” AlloClae is FDA compliant, which is “not quite the same as it being FDA approved,” the outlet said. Because human fat tissue is considered an existing product, it is “not subjected to the same standards as cosmetic interventions such as botox, dermal fillers or breast implants.”

Others are worried that fears about the origins of AlloClae could have a negative impact on organ donation. If people start “restricting their participation” due to fears of the product being used for cosmetic purposes, the “harm may outweigh the good,” Ryan Pferdehirt, the vice president of ethics services at the Center for Practical Bioethics, said to The Guardian. We need “skin grafts, bone marrow transplants and organ donation.” That is “far more important, I think, than the cosmetic aspects.”

A Covid-19 variant has returned with a vengeance. The BA.3.2 version, nicknamed Cicada, has now been found in over 20 states. The virus is highly mutated, making it difficult for vaccines to recognize. Though similar to other viruses, this strain has the potential to become more prevalent.

How dangerous is the variant?

The Cicada variant earned its name because, like the insect, it “first appeared back in 2024, went dormant for a while and resurfaced in the U.S. late last year,” said Northeastern Global News. BA.3.2 descended from the omicron variant of the Covid-19 virus, which made its debut in 2021.

Compared to current circulating strains of Covid-19, “BA.3.2 carries 70 to 75 genetic changes in its spike protein, the part of the virus that helps it get into cells,” Kyle B. Enfield, an associate professor of medicine at the University of Virginia, said at The Conversation. The spike protein is the “part of the virus that vaccines rely on to coax people’s immune systems into recognizing the virus.”

The strain is making its rounds in the U.S. and can cause similar symptoms to other Covid strains as well as other respiratory viruses, including runny or stuffy nose, fever, chills, sore throat, cough and sometimes nausea and vomiting. These similarities make it difficult to determine whether you have Covid-19 or another illness. We cannot predict “what someone has based on what is circulating,” Geeta Sood, an epidemiologist at Johns Hopkins Bayview Medical Center, said to NBC News. “It could be Covid, it could be influenza, and now we have added the prolonged RSV to the mix.”

While the Cicada variant is passing through the population, there hasn’t been any “data which indicates that Cicada is any more severe than other circulating variants,” Robert H. Hopkins Jr., the medical director of the National Foundation for Infectious Diseases, said to USA Today. In addition, Cicada is “currently a minority strain, based on the most recent data.” However, “we don’t know how quickly it will circulate or whether it will outrun the other variants that are out there at the moment, because we don’t know how contagious it is,” William Schaffner, an infectious disease expert at Vanderbilt University Medical Center, said to Politifact.

What precautions can you take?

The current vaccines for Covid-19 are “made to protect against strains from the JN.1 lineage of the virus, which have been the most common strains in the U.S. since January 2024,” said Enfield. BA.3.2 doesn’t fit the bill and is “almost a complete stranger” to those in the U.S.

“There definitely are quite a few mutations with this one, so there’s concern that the current vaccine is not going to be a great match,” said Brandon Dionne, an associate clinical professor of pharmacy and health systems sciences at Northeastern University, to Northeastern Global News. Despite this, experts still recommend getting the vaccine, as doing so can reduce the chance of hospitalization and death from the virus. A “poorly matched vaccine simply won’t recognize the new variant as quickly, which means it takes longer for the immune system to mount its defense,” Enfield said.

Along with getting vaccinated, the best thing to do is “when sick, get tested,” said Rajendram Rajnarayanan, the assistant dean of research and associate professor at the New York Institute of Technology College of Osteopathic Medicine at Arkansas State University, to USA Today. “If positive, stay home until better and confirm with a negative test. If that’s not possible, wear a fit N95 mask.”

The Centers for Disease Control and Prevention (CDC) is struggling. The agency tasked with protecting the health of U.S. citizens has lost a quarter of its staffers over the last year, morale is lousy for those who remain and for the moment the organization has no leader: Its last Senate-confirmed director was ousted in August and no replacement has been chosen.

Health and Human Services Secretary (HHS) Robert F. Kennedy Jr. promised to restore trust in the CDC following the Covid-19 pandemic. But can his “Make America Healthy Again” (MAHA) movement survive the turmoil?

Why MAHA might be stalled

Kennedy’s MAHA agenda “appears to be stalled,” said The Guardian. The CDC lacks a director, and Trump’s nomination of Casey Means to be U.S. surgeon general is “stuck in limbo” in the Senate. But the administration “isn’t ready to nominate a new CDC director” despite a deadline of last week to do so, said CNN. Administration officials are still “evaluating candidates” who can shift the CDC “to its original mission of fighting infectious disease,” said HHS spokesperson Andrew Nixon.

The CDC nomination delay comes as MAHA and Kennedy “appear to be on the ropes,” Tom Bartlett said at The Atlantic. MAHA supporters are “angry” that Trump is shielding herbicide makers from legal liability. The Food and Drug Administration’s vaccine chief just left the agency, a federal judge put a hold on Kennedy’s anti-vaccine agenda and the Kennedy-allied vice chair of the CDC’s vaccine advisory panel resigned last week. Those events, taken together, suggest the secretary’s hold on power is “waning.” A December poll “seems to have scared the White House off Kennedy’s vaccine agenda.” The result: Kenedy is “losing his grip on the CDC.”

The agency is meanwhile in “turmoil,” said The New York Times. Insiders say it is being “remade into a vehicle for ideologues” who share Kennedy’s anti-vaccine agenda. The shift prompted a staff exodus that leaves public health advocates concerned that Americans will be “increasingly exposed to a wide range of health threats” amid surges of measles, whooping cough and flu infections.

White House avoids controversy

Federal law says that acting agency directors “may not serve in the role for more than 210 days,” said The Hill. That deadline passed last week. National Institutes of Health Director Jay Bhattacharya, who had been serving as acting director, has been “delegated to provide continuity in day-to-day CDC processes” until a permanent replacement is confirmed, said a White House spokesperson.

Getting Senate confirmation is a “potentially tall order,” said Axios. Kennedy and other Trump health appointees have “antagonized some of the chamber’s Republican centrists.” The White House is especially “eager to avoid further controversial health moves” ahead of November’s midterm elections. So Trump’s eventual CDC pick “may need both MAHA and science chops,” said Roll Call. Key GOP senators “want a moderate public servant” who can last in the job. The administration, said Sen. Lisa Murkowski (R-Alaska), does not have a “very encouraging track record thus far.”

‘How risky can the weight loss drug boom be? I learned the hard way.’

Jimmie Wilson at The Washington Post

GLP-1 popularity “has also fueled a thriving market for unregulated copycat versions,” and “most patients have no idea how risky these knockoff drugs can be,” says Jimmie Wilson. What “many doctors may not know is that compounded drugs and name-brand drugs are not the same.” Compounding pharmacies “exist to make custom formulations for patients who can’t take branded medications.” They “were not intended, nor are they equipped, to safely mass-produce drugs such as” GLP-1s.

Read more

‘Did Gen Z show up to this “No Kings” protest? Sort of.’

Haley Taylor Schlitz at The Minnesota Star Tribune

It is “easy to ask, ‘Where was Gen Z?’ in a way that sounds like an accusation, as some have done after previous ‘No Kings’ protests,” says Haley Taylor Schlitz. For “young people, public outrage has rarely arrived as a singular moral awakening.” It is “not whether Gen Z wants a king,” but many “have been politically formed by an era in which speeches, protests and hashtags too often end the same way: with emotional release and too little change.”

Read more

‘The WNBA is taking off. What took so long?’

Keia Clarke at Time

The WNBA’s “cultural and economic influence can no longer be denied,” says Keia Clarke. WNBA players “are set to become some of the highest-paid women athletes in the world,” and “that kind of growth prompts a harder question: why did it take so long?” From the “beginning, there was optimism and real conviction about what women’s basketball could become. But belief and scale are not the same thing.” Fans “can’t invest in what they don’t see or what they don’t understand.”

Read more

‘The problem isn’t Washington. It’s us.’

Eugene Scott at The Boston Globe

Viewing “fellow citizens’ ethics and morals negatively is a logical conclusion after the electorate has continued to elect leaders who most people view negatively,” says Eugene Scott. It is “not unreasonable to conclude that people who support unethical leaders must have poor ethics themselves.” But lawmakers are “not primarily products of Washington. They are a reflection of the people and communities who sent them there.” If “you want to change Washington, you have to change your neighborhood.”

Read more

The UK was once a “world leader” in organ transplants, said the BBC’s “File on 4 Investigates”. But it has “fallen behind”.

In 2024, the number of heart transplants carried out per million people in the UK was lower than in most European countries, thanks to a lack of investment, resources and “outdated” technology. Waiting lists for organs are at a record high, while family consent rates for donation have fallen dramatically since the “opt-out” presumed consent system was implemented.

What’s going wrong?

“Organ donation is in crisis,” said Martha Gill in The Observer. Last year, the waiting list for an organ reached its highest on record, according to NHS Blood and Transplant: an 8% year-on-year increase. “As a consequence, many will die waiting for a phone call.”

There are only five heart and lung transplant centres in England, and one heart transplant centre in Glasgow. Anyone living in Wales or Northern Ireland must travel for a transplant, and there is significant regional variation in waiting times.

Half of the six main centres have also “lost their top surgeon in the past two years”, said the BBC. Others are leaving for jobs abroad: a “brain drain” of experts. Without experienced mentors, junior surgeons are increasingly “risk averse” and only using the healthiest donated organs, said Jorge Mascaro, Birmingham’s former director of cardiothoracic transplants (now based in the US). “It’s getting worse.”

The number of organs donated in the UK per head is equal to, or greater than, most of Europe. But the NHS transplants far fewer hearts and lungs than most countries, said the BBC. “Some countries make use of twice as many.” Surgeons say this is down to a lack of equipment and new technologies used abroad, such as machines that can scan organs to check if they are diseased. Ice boxes are often still used to transport organs between hospitals, which can harden them.

Operations are also regularly cancelled thanks to a lack of theatre space, hospital beds or staff. Post-transplant patient care is crucial to prevent complications, but the NHS “continues to struggle” to provide long-term support: the UK’s five-year survival rates “lag behind”.

Has the opt-out system failed?

When the “opt-out” system of presumed consent was implemented in England in 2020, “expectations were high”, said Gill. But the number of donors has been “crashing”. In the year to March 2025, there was a 7% decrease in the number of deceased organ donors, according to the Organ and Tissue Donation and Transplantation Activity Report. Life-saving transplants also decreased by 2%.

Most people support organ donation in theory, and nearly half the population have signed the Organ Donor Register, according to Organ Donation. But relatives have the final say; family consent rates have dropped from 69% to 61% over the past five years. Surveys suggest a “common reason: they didn’t know what their relative wanted”, said The Observer. The types of deaths that make donation possible – usually traumatic, sudden deaths of young healthy people – make it even harder for families to decide.

The presumed consent of the opt-out system acts as a “weaker signal of underlying preference” than the active consent of an opt-in system, said researchers at the Max Planck Institute for Human Development in a 2024 paper. This “uncertainty” means families are “more likely to refuse consent”. Evidence suggests an opt-out model alone doesn’t boost donations: it must be accompanied by a framework of logistics, psychological support and education.

What can be done?

The NHS and campaigners are calling for “better education in schools”, said The Mirror: for organ donation to be included in curriculums, and campaigns particularly targeted at ethnic minorities (among whom the family consent rate is significantly lower).

Evidence suggests an opt-out model alone doesn’t boost donations. Countries must invest in healthcare infrastructure, psychological support for families, and public awareness campaigns to encourage people to discuss their wishes. Family consent rates increase to almost 90% if the deceased has done so.

A government-commissioned review of heart and lung transplant services, published in 2024, made various recommendations, including better holistic care, a single-service model across the multiple centres, and “rapid-short term actions to improve organ acceptance decision-making”, said NHS England.

NHS England has since been abolished; responsibility for transplant services now lies with the Department of Health and Social Care. In a statement to the BBC, the department said the government had inherited a broken NHS, and that it recognised the “systemic issues” facing transplantation. The government said it would write to the NHS demanding that it “urgently implement” the recommendations, to make transplant services “fit for the future”.

Male-pattern hair loss affects 80% of men at some point in their lifetime (and female-pattern hair loss affects half of all women over the age of 70). But “until recently, we knew remarkably little about how to slow, halt and reverse its seemingly inevitable onset”, said Tom Howarth on BBC Science Focus.

For all the recent messaging about “body positivity”, the search for a balding “fix” has become “increasingly desperate – and financially lucrative”, said Esquire. The hair-loss industry is well on track to be worth £9 billion by 2030.

Balding happens when hair follicles on parts of the scalp produce gradually thinner and lighter hairs, until eventually they shrink and stop producing hairs at all. Until now, conventional treatments have focused on drugs that might help stimulate hair follicles or stop them shrinking. But they don’t work for everyone, can have unpleasant side effects and aren’t always available on the NHS. Other “solutions”, from micropigmentation to hair transplants and scalp-reduction surgery, have mixed results and can be very expensive. But now scientists think they have found new ways to make things look much better up there.

Hair loss cures in the pipeline

“Declarations of hair loss cures” have always been “a dime a dozen,” said Popular Mechanics, but recently there have been signs of genuine progress with new techniques – either to replace shrinking hair follicles with healthy ones or to use stem cell therapy to regenerate hair growth.

An “early frontrunner” is hair cloning, said Howarth on BBC Science Focus. Also known as hair multiplication, it’s a form of “hair banking”: before baldness hits, healthy hair follicles are extracted from your scalp and cryogenically frozen; once hair-thinning starts, these follicles are taken to a lab and the skin cells around them are isolated and multiplied; these “cloned” cells are then injected into balding patches on your head to produce lovely new hairs. A few private clinics already offer hair cloning in the UK; it’s pricey but costs may come down as the market increases.

For those whose days of hair-banking possibility are long behind them, autologous fat grafting holds some promise. Stem cells, harvested from fat cells taken from the belly, are injected into the scalp to stimulate hair growth. A study review of this technique, published in the Journal of Cosmetic Dermatology, found it to be “effective” in supporting hair regrowth and increasing hair density and diameter.

Meanwhile, in Japan, researchers are having success with their quest to grow hair follicles from scratch in a lab. Their “bioengineered hair follicle germ” has achieved follicle growth in mice, according to a study published in Biochemical and Biophysical Research Communications. It’s a milestone in hair-treatment technologies, said Popular Mechanics.

Which is the most promising?

The “big one” is a drug called PP405, developed by US pharmaceutical company Pelage, said Lane Brown in New York Magazine. “The internet’s gathering places for the bald and balding” went wild when news broke that, in Pelage’s early clinical trials, it seemed not only to slow hair loss but to reactivate “parts of the scalp that have already surrendered”.

“We were blown away,” said Qing Yu Christina Weng, Pelage’s chief medical officer, told the magazine. After four weeks of applying the drug as a topical gel, not only were the treatment group “growing new hair where there wasn’t any before, it wasn’t peach fuzz or baby hair – it was proper, thick, terminal hair”. By week eight, 31% of those treated with PP405 had a 20% increase in hair density, compared to 0% in the placebo group, according to a Pelage press release.

The drug, which is designed to stimulate the activity of a metabolic enzyme called LDH in hair-follicle stem cells, still has further, bigger trials and safety tests to get through before it can be approved by regulators. But, if it is, its potential is obvious. “After decades of snake oil and broken promises,” it feels as though “the end of baldness” is within sight, said Brown. Call it “the faint stubble of hope”.

‘Afroman: American patriot’

Greg Lukianoff and Adam Goldstein at The Washington Post

Rapper Afroman “demonstrated in often hilarious fashion why America’s commitment to freedom of speech is the dread of tyrants big and small,” say Greg Lukianoff and Adam Goldstein. Police officers “raided his rural Ohio home in 2022,” and Afroman “responded the way artists have responded to being wronged since time immemorial: turning it into art.” A “country is free when the citizen mocks the state actors who harmed him and the system defends his right to do it.”

Read more

‘Trump’s video game war: AI, memes and a simplistic narrative have flattened the conflict in Iran’

Nesrine Malik at The Guardian

The “war on Iran, even as it spreads and destabilizes the Middle East and the global economy, is not real. This is how it is being portrayed by the Trump administration,” says Nesrine Malik. The “war is a video game, a spectator sport, a social media festival of dunking,” and the “architects of this war have made a virtue out of stupidity.” The conflict “feels like the first of its kind in the modern age: distinctly remote and profoundly ignorant.”

Read more

‘Doctors should be paid to keep patients healthy’

Ashish K. Jha and Thomas C. Tsai at The Boston Globe

Experience “points to a promising idea that has been at the center of health care reform for more than a decade: Instead of paying doctors and hospitals for every test and procedure they perform, pay them for keeping patients healthy,” say Ashish K. Jha and Thomas C. Tsai. In this “model, called value-based care, doctors and hospitals are paid based on the health outcomes they achieve and the overall cost of caring for their patients.”

Read more

‘Energy crises must accelerate the fight against climate change’

Le Monde editorial board

As the “U.S.-Israeli war against Iran enters its third week, hopes for a short, contained crisis without major consequences for the global energy market have faded,” says the Le Monde editorial board. But the “absence of supply disruptions should not obscure the main point.” The “structural vulnerability of our economies to imported crises remains, now manifesting through price volatility, strategic uncertainty and the weakening of industrial supply chains.” This is “what makes this crisis different and politically decisive.”

Read more

This super mineral is crucial for everyday health. But while many are taking it in supplement form in accordance with the latest social media trend, experts say there’s a healthier way of consuming the recommended amount in your diet.

Why is magnesium so popular?

The mineral is needed to “regulate our nerves, bones, immune system and blood sugar levels,” said The Independent. It is one of the most abundant minerals in the human body and is responsible for “more than 300 biochemical reactions,” including keeping the heartbeat steady and assisting in the production of energy and protein. Despite its abundance, the body does not naturally produce magnesium, so we need to acquire the mineral from food or supplements.

In the past few years, magnesium supplements have gone viral in social media wellness circles. It is the “key ingredient in #sleepygirlmocktails”, in which a powder is “stirred into tart cherry juice and prebiotic soda,” creating a “wellness cocktail for anxious millennials,” said Wired. People are “popping magnesium glycinate before bed instead of melatonin” because it “allegedly cures insomnia, constipation and existential dread.” Last year, Google searches for “which magnesium is best for sleep” and “which magnesium makes you poop” more than doubled.

Nutrients come “in and out of vogue in our society,” Whitney Linsenmeyer, a spokesperson for the Academy of Nutrition and Dietetics, said to Parents. Magnesium is “having a moment right now,” perhaps because it is an “important nutrient in supporting common health concerns” like sleep, anxiety and PMS.

Magnesium glycinate capsules are commonly used for sleep issues and anxiety. Magnesium citrate usage is trending for constipation relief. Many social media users have posted about their “lack of bowel movements” and how drinking magnesium citrate “went above and beyond (sometimes too far) to get them back on track,” said Parents.

Should we be taking the supplements?

Unless you have a magnesium deficiency, “magnesium supplements aren’t essential,” said Wired. If you are struggling with “migraines, insomnia or other conditions where research suggests health benefits,” they may be worth trying, but “first talk to a health care professional.” Instead of supplements, you can focus on consuming “magnesium-rich foods” such as legumes, leafy greens, whole grains, nuts, fruits and soy products. Dark chocolate is also a good source of magnesium.

Deficiencies can be difficult to detect, Louise Dye, a professor of nutrition and behavior at the University of Sheffield, said to the BBC. Still, it is believed that we’re not getting enough magnesium from our food. Over the past 60 years, “intensive farming practices have caused a significant depletion of the mineral content of the soil,” including a “decrease in magnesium of up to 30%.” Additionally, “western diets typically have a greater proportion of processed food, where numerous products are mostly refined,” leading to magnesium being “depleted by up to 80-90% in the process.”

Supplements can be risky, however, and “overdosing may even be deadly,” said The Independent. Too much magnesium from food “does not pose a health risk in healthy individuals because the kidneys eliminate excess amounts in the urine,” the National Institutes of Health said. But high doses of magnesium from dietary supplements or medications “often result in diarrhea that can be accompanied by nausea and abdominal cramping.” Other symptoms may include low blood pressure, thirst, drowsiness, muscle weakness and slow or shallow breathing. Extremely high doses can lead to irregular heartbeats or even cause the heart to stop altogether, according to Cedars-Sinai Medical Center.

Warming temperatures from climate change will likely lead to high levels of physical inactivity in the future, which could have significant public health implications. Heat leads to dehydration, exhaustion and overall inhospitable conditions. Regions with less air conditioning and cooling facilities will see the highest reduction in activity, but without intervention, more places will be affected.

Running hot

Rising temperatures are “projected to increase the prevalence of physical inactivity, translating into additional premature deaths and productivity losses,” said a study published in The Lancet Global Health. The study analyzed data from 156 countries between 2000 and 2022 to create a model for future physical activity globally. The results showed that by 2050 “each additional month with an average temperature above 27.8°C (82°F) would increase physical inactivity by 1.5 percentage points globally and by 1.85 percentage points in low- and middle-income countries,” said a release about the study.

With this reduction in physical activity, there would be a “predicted 0.47-0.70 million additional premature deaths annually and $2.40-3.68 billion in productivity losses,” said the release. The effects were mostly concentrated in low- and middle-income countries, and “some hot spot countries closer to the equator show estimated increases in physical inactivity of more than 4 percentage points by 2050,” said The Washington Post. On the other hand, high-income countries had no discernible difference in physical activity levels because they tend to have better infrastructure to combat heat.

The inactivity levels would increase gradually. The “real-world picture is usually not that people suddenly stop moving altogether,” the study’s lead author Christian Garcia-Witulski, a research fellow at the Lancet Countdown Latin America and a professor at the Pontifical Catholic University of Argentina, said to the Post. Instead, “heat gradually erodes the safe, comfortable and practical opportunities people have to stay active in everyday life.” Warmer temperatures would hinder activities such as “jogging outdoors or walking to work, particularly in areas which don’t have strong adaptive measures like proper shading or cool pavements,” said Time.

Internal conflict

Even without the climate pressure, “nearly one third (31%) of the world’s adult population, 1.8 billion adults, are physically inactive,” said the World Health Organization (WHO). Between 2010 and 2022, the number of people who “do not meet the global recommendations of at least 150 minutes of moderate-intensity physical activity per week” increased by 5%. Climate change is only expected to increase the number further. While lower-income countries face the brunt of the decrease in physical activity, “the pattern was not uniform,” and “some colder areas, such as North America, Argentina and South Africa, also report high rates of physical inactivity,” said the study.

“Outdoor laborers, street vendors and subsistence farmers cannot easily shift physical exertion to cooler hours,” said the study. Also, “women and adolescents often lack access to climate-controlled recreational spaces.” Physical activity “contributes to prevention and management of noncommunicable diseases such as cardiovascular diseases, cancer and diabetes and reduces symptoms of depression and anxiety,” said WHO.

“The link between physical inactivity and chronic diseases is so strong that any compromise to achieving regular exercise” will “pose broad public health risks,” Jonathan Patz, the chair of health and the environment at the University of Wisconsin-Madison, said to the Post. Prioritizing reducing greenhouse gas emissions as well as building cooling infrastructure will be necessary for human health.

People agree that smoking is bad for you, but nicotine has far from gone up in smoke. Levels of American adults smoking cigarettes hit a record low in 2024, but nicotine products like vapes, patches and gum are alive and well.

Of the wide array of nicotine products, none have been picking up speed the way pouches like Zyn and On! have. These products are usually the size of a piece of gum and are held in the mouth between the gums and teeth, which slowly releases nicotine into the body. While mainly touted as a method to quit smoking, the pouches have made their way into the wellness spaces and are also being used as a tool to improve concentration.

How are nicotine pouches gaining popularity?

For those looking to quit smoking, nicotine pouches are considered to be the “least harmful nicotine option” because they are not known to “cause cancer, lung disease or other ailments,” by themselves, said The Wall Street Journal. But nicotine pouch usage is not exclusive to those trying to quit smoking.

The addictive chemical has a new lease on life, with many touting its benefits. Some studies have found that nicotine can improve cognitive performance, including attention, memory and learning. Nicotine has also been “linked to weight loss and reduced appetite,” as it “appears to influence the parts of the brain that control hunger and makes the body burn more energy,” Dipa Kamdar, a senior lecturer in Pharmacy Practice at Kingston University, said in an article for The Conversation. The pouches have similar effects to GLP-1s, which have been used for weight loss.

Nicotine pouches have since been touted as a powerful wellness compound, especially in the right-wing and biohacking spaces. It is a “life-enhancing, God-given chemical,” right-wing media personality Tucker Carlson said on Instagram. He claims that nicotine can treat erectile dysfunction and released his own brand of pouches called ALP, in collaboration with the tobacco giant Turning Point Brands. Over time, many media personalities have “advocated for nicotine use, not just as a way to get a buzz but as a cure for ailments ranging from whooping cough to atrial fibrillation,” said Salon.

The nicotine pouch hype has also skipped into the workplace. Rather than strictly drinks and snacks, the tech company Palantir began stocking nicotine pouches as a job perk, hoping to increase workers’ focus and productivity. Nicotine startups Lucy and Sesh have “installed branded vending machines in Palantir’s Washington, D.C., office,” said Fortune. This is “just one of the ways biohacking has taken the Silicon Valley tech space by storm.”

Is there merit to the benefits?

Any health benefits associated with nicotine are “frequently overblown or misinterpreted” and “outweighed by the problem of addiction,” said Stat. These effects are particularly dangerous as young people and those who have never smoked are picking up the habit. The chemical’s addictive nature can “become a gateway for someone to start using more harmful forms of nicotine, including cigarettes,” said the Journal. Most nicotine pouches on the market are also not FDA-authorized. Only certain Zyn and On! products have received authorization. Still, authorization differs from approval, as “all tobacco products are harmful and potentially addictive,” said the FDA.

Regarding cognitive enhancements, “people who already have cognitive difficulties have more room to improve, while those with healthy brain function are already performing close to their best,” said Kamdar. Nicotine is ”unlikely to offer any real benefit to people who don’t have cognitive impairments.”

What most experts agree on is that nicotine pouches are one of the better ways to quit smoking because most of the danger from cigarettes comes from the combustion of tobacco and not the nicotine itself. Evn though nicotine can cause other issues like nausea, vomiting, harm to blood vessels and an increased risk for heart attack and stroke. “Wellness trends come and go,” said Kamdar, “but addiction is far harder to shake.”

‘Banky’s anonymity is what gives — gave? — his art its power’

Allison Schrager at Bloomberg

The “revelation that the artist Banksy is a 50-something man from Bristol, England, named Robin Gunningham” might “be the ultimate test of what actually determines value in contemporary art,” says Allison Schrager. Art insiders “are speculating that the news will increase the value of Banksy’s work. That line of thinking tracks with the fact that markets hate uncertainty, and now there is more clarity.” But Banksy’s “art is not like a stock option or any other commodity.”

Read more

‘The farm bill, in its current state, is a public health failure’

Lyndon Haviland at The Hill

Congress is “trying to pass a long-overdue farm bill as lawmakers debate where, and how, billions in taxpayer resources should be allocated,” says Lyndon Haviland. But “those involved in shaping the current legislation seem to be more interested in protecting special interests than advancing the bill’s primary objectives: establishing a healthy food system, supporting a wide group of farmers who supply it and ensuring all Americans have access to a safe and nutritious food supply.”

Read more

‘Great powers can learn from small island states’

José Ulisses de Pina Correia e Silva at Newsweek

Small island countries are “uniquely placed to navigate today’s changing world,” says Cape Verde Prime Minister José Ulisses de Pina Correia e Silva. Their “size and focused economies, rather than making them vulnerable, have made many capable of addressing global economic shocks and thrive as the shift occurs from the ‘globalization generation’ to a new arena of great power play.” Small size “also means economic expansion is focused on the practical,” with “no room for overpromising.”

Read more

‘Medical students and doctors aren’t supposed to do invasive exams on surgery patients without permission. My research found it’s still happening. Here’s what should be done.’

Phoebe Friesen at the Toronto Star

The “practice of medical students performing pelvic exams on anesthetized patients without their consent has had a lot of press in recent years — at least in the United States,” says Phoebe Friesen. But in Canada “nonconsensual educational sensitive exams” are “alive and well.” It is “time for Canada to get clear on consent for educational sensitive exams under anesthesia,” and “time for medical schools across the country to implement policies ensuring explicit consent takes place before each educational exam.”

Read more

Step aside, girl dinner! Boy kibble is, according to social media, the new way to eat. Focused on protein loading and very little else, the trend is popular among Gen Z men and glorifies eating a bowl of tasteless mush. But it also reflects a push toward disordered eating and hypermasculinity.

Dog food for humans

Referring to the food as kibble is no accident, as most of the time these recipes involve a carb (like rice) and a form of protein (like ground beef) mixed together in a slop-like concoction that has glaring similarities to dog food. “Pleasure-seeking details like flavor and aesthetics are tossed to the side,” said The New York Times. However, this form of dinner may be “less nutritionally complete even compared to what you may be feeding the four-legged members of your family,” said Parents.

While some will opt to add vegetables to their kibble, for the most part, the goal is to maximize the amount of protein consumption, often at the expense of overall nutritional value. Many of these meals forgo fruits, whole grains and healthy fats. “When your meals lack these essential nutrients, deficiencies in fat-soluble vitamins and essential fatty acids, and micronutrients like calcium, vitamin D and iron, can result,” said Parents. Also, the “lack of fiber in boy kibble puts kids at risk for constipation and does not support a healthy gut microbiome,” Madison Szar, a pediatrician with Bluebird Kids Health, said to the outlet.

“Proteinmaxxing” is a trend increasing in ubiquity among young men, especially as Health and Human Services Secretary Robert F. Kennedy, Jr. rolled out new diet guidelines emphasizing protein consumption. At the same time, “grocery prices and fitness trends continue to shape online food culture,” said Newsweek. With these combined factors, boy kibble “reflects a broader shift toward streamlined, protein-forward meals that prioritize convenience over presentation.”

Healthy facade

The goal of eating boy kibble is to consume an easy, nutritional meal, even if the nutritional value is debatable. But the boys are largely ignoring seasoning, making the meals themselves not very tasty or enjoyable, a mere means to an end. “This kind of moralizing of food or turning suffering through meals into a badge of honor” can “map on to some kind of disordered eating patterns and risks, no different than, say, orthorexia,” Abbey Sharp, a registered dietitian and the author of the book “The Hunger Crushing Combo Method,” said to Fortune.

The entire movement is a male response to the 2023 girl dinner trend, “where women devised elaborate hodgepodges of charcuterie-like plates, consisting of assorted meats, breads, cheeses, fruits and leftovers,” said Fortune. While girl dinner showcased the tendency to cobble together meals from things readily available in the kitchen, tying the slop-consumption to the word “boy” helps “soften what could be perceived as toxically masculine consumptive behaviors,” Emily Contois, an associate professor of media studies at the University of Tulsa and the author of “Diners, Dudes and Diets: How Gender and Power Collide in Food Media and Culture,” said to the Times.

The entire branding of boy kibble is “served with a heavy dose of internet irony,” said Newsweek. Using the term is “allowing men to sidestep the more feminine aspects of dieting,” Adrienne Bitar, a professor at Cornell University who studies the culture of American food and health, said to the Times. Dieting has been “seen as vain, frivolous, attention-seeking, superficial,” but by taking part in a trend, men can say “this isn’t about vanity” or “appearance, necessarily” but instead about “optimization and quantifying how to become my best self.” The trend reflects a recent “backlash moment of men wanting to reclaim a more traditional, conventional masculine authority.”

What happened

A federal judge in Boston on Monday paused most of Health Secretary Robert F. Kennedy Jr.’s consequential actions on vaccines, as well as the decisions made by the influential vaccine advisory committee he gutted and remade with handpicked members. U.S. District Judge Brian Murphy, siding with the American Academy of Pediatrics and five other medical groups, said Kennedy had likely violated legal administrative procedures in appointing his new Advisory Committee for Immunization Practices, then illegally sidestepped his handpicked panel in January to shrink the federal schedule for childhood vaccines from 17 routine immunizations to 11.

Who said what

Since 1964, “all U.S. vaccine policy has first run through ACIP, an independent panel of vaccine experts” that guides the Centers for Disease Control and Prevention’s recommendations, CNN said. The committee has historically decided which vaccines are safe and effective through “a method scientific in nature and codified into law through procedural requirements,” Murphy ruled. But under Kennedy, the “government has disregarded those methods and thereby undermined the integrity of its actions.”

The ruling from Murphy, an appointee of former President Joe Biden, is a “severe blow to the Trump administration’s health agenda,” The New York Times said. But the “blow to Kennedy’s efforts to overhaul federal vaccine policy” landed “at a time when the White House is seeking to limit vaccine critics’ influence within the administration,” Axios said. Kennedy wants federal vaccine policy “to more closely reflect” his skepticism of vaccines, Politico said. But the White House is looking to “shift the focus ahead of the midterms away from vaccines, which the public overwhelmingly supports, toward priorities with widespread voter buy-in, like lowering prescription drug costs.”

What next?

Murphy’s order effectively blocks ACIP from meeting Wednesday and Thursday, as planned. But it’s “not the final word,” The Associated Press said. His ruling bars 13 of ACIP’s 15 members from serving on the panel, freezes all the committee’s decisions since June and halts Kennedy’s reduced immunization schedule “pending either a trial or a decision for summary judgment.” The Trump administration is expected to appeal the ruling.

The United States has generally had a more forgiving set of regulations governing the use of additives, preservatives and other chemicals in food and drinks than the European Union (EU). The difference has begun to narrow, however, both because some U.S. states are banning ingredients that the federal government allows, and because the Health and Human Services Secretary, Robert F. Kennedy Jr., pledged to more aggressively prohibit some of these substances as part of his Make American Healthy Again (MAHA) movement.

Some substances that were once legal to use in foods in the U.S. but not in Europe, like partially hydrogenated oils as well as brominated vegetable oil (BVO), were banned in the U.S. prior to the second Trump administration. They included a food dye called Red No. 3, which was banned by the Food and Drug Administration (FDA) on January 15, 2025. In April 2025, Secretary Kennedy announced plans to work with the food industry to voluntarily phase out six other petroleum-based food dyes, all of which are already banned for use in foods in the EU.

Azodicarbonamide (ADA)

ADA is used in the U.S. to “whiten cereal flour and improve baking bread dough,” said CBS News, but is banned for use in food by the EU, where it is considered a carcinogen. ADA has become increasingly controversial, however, and some companies have rolled back its inclusion in certain products.

In 2014, for example, Subway announced that it would no longer use ADA in its bread products, which turned out to be the leading edge of a trend. The American Bakers Association announced in 2026 that most of its members had already phased out the use of ADA, with the remainder doing so by the end of the year. The FDA is currently reviewing information about ADA.

Butylated hydroxyanisole (BHA)

BHA “is a preservative used in cured meats and other foods,” said the Environmental Working Group, a U.S.-based nonprofit. It is “subject to severe restrictions in Europe” but continues to be added to American food products under the FDA’s GRAS (Generally Regarded as Safe) principle, said The New York Times. The National Toxicology Program deemed it a likely human carcinogen decades ago. In February 2026, the FDA ordered a new safety review of BHA, “pointing to long-standing concerns that the food additive might cause cancer in humans,” said NBC News.

Butylated hydroxytoluene (BHT)

BHT is an “antioxidant that helps stabilize vegetable oils so they stay fresh longer and is often used in crackers and cereals to extend their shelf life,” said Tasting Table. The antioxidant’s presence in the popular cracker Wheat Thins, for example, is the reason you won’t be able to find them in Europe. Due to “concerns related to potential endocrine-disrupting properties,” BHT is banned for use in foods in the EU, said the European Commission. In August 2025, the FDA launched a “postmarket assessment of the safety of BHT as used in food and food contact materials,” said the FDA.

Potassium bromate

Potassium bromate is a substance that is found “usually in the form of fine crystals or powder, to strengthen dough” in more than 100 products sold in the U.S., said CBS News. It has been used for more than a century in breadmaking, but the European Union, the United Kingdom, Canada and most other countries in the world consider it a human carcinogen.

While Secretary Kennedy’s HHS has not taken any direct action against potassium bromate, he has stated that he wants to eliminate the program under which it is used in the U.S., under the FDA’s GRAS designation. Critics say that GRAS allows companies to include ingredients that were “greenlit for use not by the FDA but by the food and chemical industry,” said CNN.

Propylparaben

The chemical is deployed in more than “50 products in U.S. grocery stores,” said Consumer Reports, “including many packaged corn tortillas, baked desserts and cake icing.” Propylparaben helps “stop the growth of microorganisms in most packaged foods,” said The Cleveland Clinic, but may “interfere with your endocrine system, which includes glands and the hormones they send out to tell organs and tissues what to do.” The EU banned the inclusion of propylparabens in food in 2006. A 2024 FDA review did not lead to any new regulatory action.

Titanium dioxide

The “naturally occurring oxide of titanium,” titanium dioxide “has been used for decades to impart white color to many foods, from baked goods and sandwich spreads to soups, broths, sauces, salad dressing and food supplements,” said the European Commission. The EU banned its use in food products in 2022, citing the “possibility that the use of titanium dioxide as a food additive might cause DNA or chromosomal damage.” In the U.S., the “chemical seems to be largely surviving the food-dye purge” spearheaded by Kennedy, said The Atlantic, although some companies, including the maker of Skittles, are phasing it out voluntarily in expectation of future regulatory action.

Since 1959, Cuba’s so-called “white coat army” has been one of the Caribbean island nation’s most distinctive exports. “From Latin America to Africa and beyond”, thousands of highly trained medical professionals have worked to fill gaps in overstretched health systems around the world, generating valuable income for Havana in the process, said Al Jazeera.

But the long-standing scheme is now under strain, as the United States seeks to “starve Cuba of much-needed revenue” by putting pressure on its allies to stop importing Cuban medics to prop up their strained health services.

‘Coercive labour’

“For decades” the Cuban government has sent healthcare professionals to work overseas in diplomatic arrangements in which host nations pay Havana directly for the services of its medics, said The New York Times. Doctors are dispatched to “work in remote villages and cities in dozens of countries” where local healthcare systems have difficulty filling posts, but the medics themselves only receive a “small fraction” of what is paid for their services. It is “unclear” exactly how much Cuba has received from such arrangements, but research estimates a revenue of around $4 billion (£2.9 billion) a year from the export of skilled workers, including healthcare workers and teachers.

US officials argue that the programmes amount to a “coercive labour export scheme”, said the Financial Times. The US has expanded visa restrictions on those involved in medical missions, including officials in host countries, whom it accuses of participating in “forced-labour practices”. Last year, it imposed travel restrictions on several officials from Brazil, “once a top destination” for Cuban doctors but where numbers have now rapidly fallen amid increasing pressure from the US.

‘Close to collapse’

“After nearly 50 years”, arrangements will draw to a close in Guyana, said the Associated Press, while “several other Caribbean countries” including St Lucia, Antigua and Dominica are also reviewing their programmes. Medical missions have also ended in staunch Cuban ally Venezuela, as well as Guatemala.

Cuba framed the end of the medical mission in Jamaica as the nation “yielding to US pressure”, said Cuba’s 14ymedio. But Jamaica’s “version is different”, alleging that Cuba “did not even respond” to a proposal to pay doctors directly for their work.

The impact is being felt well beyond the Americas. In Calabria, one of the poorest regions in Italy, the arrival in recent years of 400 Cuban doctors has been “essential to keeping local hospitals running”, said Reuters. But, under duress from Washington, Calabria has now “scrapped plans” to hire 600 further doctors, and is now scrambling in a “global search for medical staff” expected to cost the region €8 million (£6.9 million), said Euractiv.

Giuseppe Ranuccio, vice-president of the Calabrian regional council, told the outlet that the health system was already “close to collapse”. The Cuban doctors “were supposed to buy time for structural reforms”, he said. “But those reforms never arrived.”

Transgender people have been the focus of an aggressive legislative push to mitigate their access to health care in recent years, and now trans prisoners are facing a new offensive. President Donald Trump has instated a policy for the federal incarceration system, one that mirrors an outdated, controversial practice.

‘Culture war targeting transgender civil rights’

The Trump administration released its new policy outlining how transgender people in Bureau of Prisons (BOP) custody will be treated. Approximately 2,200 trans people held in federal prisons will be denied access to gender-affirming health care, be “subjected to constant misgendering by staff” and have items like binders, bras and makeup confiscated, said the Transitics Substack.

The policy will impose treatment targeting “psychological distress/dysphoria” through talk therapy and “psychotropic medication” like antidepressants until the gender dysphoria diagnosis is considered “resolved,” said the Transitics Substack. The new policy designates gender dysphoria as a mental illness that requires “routine mental health care.” Under the new rules, federal prisons “won’t just medically and socially detransition trans people en masse,” they will “actively try to ‘cure’ them of their gender dysphoria.” The policy has been compared to conversion therapy, a dangerous practice recognized by the United Nations as a form of torture.

The changes align with an executive order Trump signed almost immediately after taking office, called “​​Defending women from gender ideology extremism and restoring biological truth to the federal government.” The order said that the federal prison system would ensure that no federal funds would be used for any “medical procedure, treatment or drug” for the purpose of “conforming an inmate’s appearance to that of the opposite sex.” In a lawsuit challenging the order, a federal judge ordered that the prison would continue providing hormones and accommodations. However, in court papers and interviews, transgender people have “described their access to hormone treatments and social transition supports as inconsistent,” said The Marshall Project.

The new policy is the “latest move amid a culture war targeting transgender civil rights nationwide,” with hundreds of anti-trans bills passed at the state-level over the last several years, said the Marshall Project. Last year, the Supreme Court upheld gender-affirming care bans for young people, which have been passed in 20 states. The decision “made it pretty clear” that a ban with “any conceivable rational basis” must be allowed, Jared Littman, a government attorney, said at the hearing announcing the prison bans. In addition to the federal policy, prison systems in Georgia, Kentucky, Utah and Florida have banned access to gender-affirming care.

‘Not just cruel but reckless’

Even before the latest policy, gender-affirming care was inconsistent for trans inmates. Denying hormones to “people in distress” and withdrawing them from “people who are stable undermines safe facility operations,” Alix McLearen, who authored earlier versions of the Bureau of Prisons’ transgender policy manuals, said to the Marshall Project. “From a corrections management perspective, this is not just cruel but reckless.”

Prisoners in Georgia are suing state officials over the state’s policy, which is similar to the federal one. If the new federal prison policy is implemented, and “it’s not enjoined, people will die,” Chinyere Ezie, an attorney representing the plaintiffs in the Georgia suit, said to the Marshall Project. People will die from suicide or will “die or be severely hurt from castration attempts.” Those who don’t lose their lives will “experience the very extreme physiological symptoms of hormone therapy withdrawal,” in addition to “psychological symptoms, including depression, anxiety and suicidal ideation.”

Rebecca-James Meskill, a transwoman incarcerated in Alabama, told Uncloseted Media she was taken off hormones following the original executive order. She did not receive them again until six months after the judge issued the injunction. During that time, she frequently broke out in hives, and the dysphoria about her body hair caused her to scratch her arms until they became scarred. Being off hormone therapy has “left me feeling diminished in every aspect of life,” Meskill said. Her body “started re-masculinizing,” and her body hair is “growing thicker and faster.” The lack of gender-affirming care makes her feel “hopeless and like I need to avoid people.”

‘The cost of chaos at the CDC’

Leana S. Wen at The Washington Post

Nearly “half of the CDC’s routinely updated databases were paused without explanation between May and October 2025,” and “without up-to-date data, health officials cannot identify gaps or direct education and outreach where they are most needed,” says Leana S. Wen. When funding is “withdrawn at this scale, local and state governments have little realistic prospect to replace it.” Even if “some of the money is eventually restored through litigation, the damage may be difficult to undo.”

Read more

‘CNN’s coverage of Iran is a reminder of its power — and what could be lost in the wrong hands’

Tom Jones at the Poynter Institute

News organizations have done an “admirable job, calling out their top reporters and anchors and having special programming to pass along vital information” about Iran, says Tom Jones. But it is “moments like these when CNN especially shines.” Despite “many criticisms, CNN continues to be a leader in national and international news and, with all due respect to the other networks, no network is better and more equipped to cover huge stories like Iran.”

Read more

‘Don’t just freeze federal assistance to fight fraud — fix the program’

Parth Patel at The Hill

Headlines have been “dominated by scandal: phantom day cares, faked receipts, and misuse of taxpayer dollars,” says Parth Patel, but these are “not an aberration. They are the predictable result of a system that measures compliance instead of outcomes.” The real “scandal of the American welfare system isn’t just that money is being stolen — it is that the money we do spend isn’t helping people escape poverty. Rather, it is trapping them in poverty.”

Read more

‘Retirement is a strategic mistake — unless we redesign life for the intelligent age’

Klaus Schwab at Time

Longevity is “not merely a medical achievement. It is a structural shift in the human condition,” says Klaus Schwab. But humans “continue to organize life according to a model designed for a 70-year or shorter lifespan. Education, career, retirement — that’s how we think about life.“ We “must apply systemic thinking to the architecture of life itself.“ A 100-year life “cannot be compressed into a front-loaded education, a 40-year career sprint, and three decades of passive withdrawal.”

Read more

A new single-pill HIV treatment has proved as effective as regimens of up to 11 tablets a day in suppressing the virus in hard-to-treat patients. It’s “a potential breakthrough for a growing cohort of long-term HIV survivors” who are resistant to standard treatments and struggle to keep to complex medication schedules, said the Financial Times.

Along with the rollout of a twice-yearly jab to prevent HIV infection, this represents “the latest advance in a scientific ‘golden age’ for treating the virus” – even as wealthy countries cut their funding.

How well does the new single-dose pill work?

Researchers recruited, from 15 countries, more than 550 people living with HIV for whom conventional therapies were no longer effective. They had a median age of 60, and many had other health conditions. Their HIV treatment involved taking between three and 11 pills a day. They were randomly assigned to continue their treatment or switch to the new single pill.

Almost 96% of those who switched continued to suppress the virus, without new signs of drug resistance, according to the study results published in The Lancet. That is a similar rate to the control group who stayed on their more complicated multi-pill treatment. But the “switchers” found the new regimen easier to follow, and experienced a decrease in some side effects, such as elevated cholesterol levels.

The findings are “game-changing” for people who have lived with the virus for decades and have conditions “associated with ageing”, said study lead Chloe Orkin, a professor of infection and inequities at Queen Mary University of London. “The participants found the regimen far more convenient.”

The pill, a combined dose of established HIV drugs bictegravir and lenacapavir, could be “transformative” for those who struggle to access clinics because of age or poverty, said Anne Aslett of the Elton John Aids Foundation. “The challenge now” is to ensure this treatment breakthrough is “complemented by political will, funding and community engagement”, she told the Financial Times.

How do the HIV-preventive injections work?

A twice-yearly jab of lenacapavir was shown in 2024 clinical trials to be 100% effective at preventing new HIV infections.

An injection like this has a clear advantage over daily prevention pills in poorer countries, where patients – particularly young women – might struggle to access clinics or feel stigmatised for seeking treatment. Last year, the World Health Organization recommended it; the director general Tedros Adhanom Ghebreyesus described it as “the next best thing” to an HIV vaccine.

There was initial concern that the drug would not be affordable in poorer countries. In the US, it was launched with a price tag of more than $28,000 (£21,000). But last year, manufacturer Gilead granted licences to six manufacturers to produce generic versions of the drug in 120 low and middle-income countries at a cost of $40 (£29) per patient per year. This is a “historic breakthrough”, said Philippe Duneton of the Unitaid global-health initiative.

Meanwhile, in October, another long-acting HIV-preventive injection, cabotegravir (given six times a year), became available on the NHS in England and Wales. (It has already been made available in Scotland). This is a “cutting-edge treatment”, said Health Secretary Wes Streeting. “For vulnerable people who are unable to take other methods of HIV prevention, this represents hope.”

What other progress has been made?

Promising results have been seen with stem cell transplantation. Seven people have been declared HIV-free after receiving a stem cell transplant – and, significantly, two of them had received stem cells that were not actually HIV-resistant.

This “upends our understanding of what’s required” for a cure, said New Scientist. If HIV-resistant cells aren’t necessary to destroy the virus, then scientists have a wider potential pool of stem cell donors, and greater options in their search for an effective HIV cure.

Other trials are exploring ways to cure HIV by genetically editing immune cells.

People “hum into their phones, gargle with theatrical enthusiasm, dunk their faces into bowls of ice water, and poke at their ears”, said Katie Edwards and Dan Baumgardt on The Conversation. They are all trying to “activate” their vagus nerve, the new “favourite body part” of the internet.

Social media is abuzz with the transformational potential of vagus-nerve “training”. Stimulate it and reset it, wellness influencers claim, and you can improve your mental and physical wellbeing.

What is the vagus nerve? 

It’s the longest cranial nerve in your body. Its name derives from the Latin for “wandering” because its two branches rove through your entire body – travelling from the brainstem down into your neck, chest and abdomen, connecting to the heart, lungs, gut and the liver. It constantly relays information from your brain to your organs and back again, and is often described as an internal communication superhighway or our body’s intranet.

How important is it? 

As “signal updater” between brain and body, the vagus nerve is a part of the autonomic nervous system that regulates processes you don’t consciously control, such as heart rate, breathing and digestion. Within that system, it has a key role in the parasympathetic response – sometimes known as “rest and digest” – slowing heart rate and decreasing blood pressure. Put simply, when you feel calm, safe and relaxed, your vagus nerve is helping to make that happen.

The theory is that your body can sometimes get “stuck” or spend too long in the opposite sympathetic response – known as “fight or flight” – and stimulating the vagus nerve can prompt a return to calm.

Can stimulating it make you healthier?

Implanted devices that directly stimulate the vagus nerve have long been used to treat neurological conditions like epilepsy and treatment-resistant depression. More recently, trials of transcutaneous devices, often placed around the neck or in the outer ear, have shown promising results in treating conditions including diabetes, Crohn’s disease, fibromyalgia and irritable bowel syndrome.

This kind of non-invasive vagus-nerve stimulation (VNS) first entered the “mainstream consciousness” as a “biohacking tool” in the 2025 Netflix documentary “Don’t Die”, said Vogue. The film followed US tech entrepreneur Bryan Johnson’s “longevity journey” and the “anti-ageing” crusader is shown wearing a VNS gadget that, he said, helps him manage stress and get to sleep.

From then on, the vagus nerve got “the trendy treatment”, said The Independent. Wearable devices swiftly appeared on the market that were said to enable VNS by sending a “specific level” of electrical current through the nerve that will “wake up” or “reset the system”, much like “rebooting a computer”.

I am cautious about claims that the vagus nerve can be “switched on like a light”, Arshad Majid, a professor of cerebrovascular neurology at the University of Sheffield, told Edwards and Baumgardt on The Conversation. There’s “not an on-off button” that these devices, or other DIY methods, like humming or gargling, can trigger. And, in some cases, trying to stimulate the nerve can “trigger headaches and even depression”.

That said, we are running various clinical trials on non-invasive VNS devices, and the “next few years of research” could “reshape” how we treat a range of conditions. But you should “maybe hold off on aggressively poking your ear” for now.

Bone broth “has undergone the PR glow-up of a lifetime”, said Saskia Kemsley in The Standard. Celebrities including Gwyneth Paltrow, Halle Berry and Kylie Jenner have all jumped on board, extolling its rejuvenating benefits.

So what is bone broth? Put simply, it's a nutrient-dense liquid made by simmering animal bones with vegetables or other natural ingredients for up to 24 hours, similar to making stock for use in soups or stews. Drinking the broth for its health benefits is a “phenomenon” that has “skyrocketed” in recent years, even if the evidence is somewhat unclear.

“Of all the wellness trends, this one’s probably up there with the strangest,” said Daisy Jones in British Vogue. “A broth? Made from bones, you say? Sounds a bit fee-fi-fo-fum to me.”

But bone broth promises an “array of supposed health benefits”. Some studies have shown that it is an anti-inflammatory “gut-healing powerhouse”, rich in electrolytes, and full of amino acids that help “regulate the immune system and promote gut health”. People are also indulging in a bid to improve their skin with the high collagen content. “Hmmm, maybe not so unappealing after all?”

Some of the most popular brands are “hugely expensive”, and often not much better than you can make at home, so you don’t need to “spend a fortune” buying the stuff, said Clare Finney in The Times. All you have to do is pop into a butcher’s for some “broken-down bones” at a “fraction of the price”, Michelin-star chef Emily Roux told the newspaper, “or if you’re making a roast chicken, never throw away the carcass”. After a four- to six-hour “long, slow simmer”, you can add combinations of “star anise, black peppercorns, any veggies or herbs that are suffering in the fridge” to “zhuzh it up”.

If you do want to splash out on a shop-bought broth, one of the best on the market is Borough Broth, whose organic beef bone broth is “filled to the brim with umami excellence” and has a “whopping 40% bone content”, said Kemsley in The Standard. Freja is another brand “taking supermarkets by storm for good reason”. Its broths have a two-year shelf-life, making them a “pantry essential”, and there’s also a fish-based version for pescatarians.

Despite the frenzied uptake by influencers who think it is a “wonder stew for your face”, some experts have a “bone to pick” with the trend, said GQ. Though it can be a great source of amino acids, the results can be inconsistent depending on what is cooked, and how.

“My personal advice would be that it doesn’t add anything that a healthy diet containing a good source of proteins wouldn’t do”, Dr Christine Hall, NHS GP and aesthetics doctor, told the magazine. “In fact, a healthy, balanced diet will actually contribute more.”

‘The protein bar delusion’

Nicholas Florko at The Atlantic

Protein bars have “come a long way from the chalky monstrosities that lined shelves not long ago,” says Nicholas Florko. For “anyone with a sweet tooth, it can feel like food companies have developed guilt-free candy. But that’s where things get disorienting.” Some protein products are “seemingly nutritionally benign, whereas others are nothing more than junk food trying to cash in on protein’s good reputation.” The “line between protein bar and candy bar has never been blurrier.”

Read more

‘How tech turned against women’

Laura Bates at the Financial Times

The “Big Tech lobby, well oiled by money and unprecedented proximity to those in positions of power, has done an overwhelmingly successful job of convincing us that regulation in their sector is a near-impossible task,” says Laura Bates. We are “sleepwalking into a new age of gender inequality, propelled at breathtaking speed by the implementation of untested AI.” Existing “forms of inequality and discrimination are being repeated and intensified by tools that have been trained on biased or misleading data.”

Read more

‘Tarique Rahman must revive Bangladesh’s economy’

Farid Erkizia Bakht at Time

New Bangladesh Prime Minister Tarique Rahman will have to “work hard to maintain political stability but his political success will depend on his primary task: reviving the economy,” says Farid Erkizia Bakht. Many “identify structural bottlenecks in distribution channels, rather than monetary policy alone, as the chief cause of elevated food prices. This is the Rahman government’s Achilles heel.” The “challenges are significant but Rahman does have a chance to revive the economy and bring stability to Bangladesh.”

Read more

‘How George Harrison transformed the music business’

Josh Harlan at The Wall Street Journal

Spotify “recently announced that it paid more than $11 billion in streaming royalties and other payments to the music industry in 2025,” and it is a “fitting occasion to recall how George Harrison, railing against Britain’s confiscatory tax regime, unwittingly helped create the template for this market,” says Josh Harlan. The Beatles’ “attempt to protect their income stream would backfire twice, costing them control of their own songs, but it also helped shape one of today’s most coveted asset classes.”

Read more

Sepsis is one of the leading causes of death and disability worldwide. It can affect anyone, and is notoriously difficult to diagnose in the early stages, and to treat once it becomes life-threatening. Now scientists in Australia are getting close to unlocking the first specific sepsis treatment.

The current first-choice treatment for sepsis focuses on using broad-spectrum antibiotics to attack the pathogen causing the condition. But there are an increasing number of antibiotic-resistant pathogens that can cause sepsis. “This is the nightmare that keeps my colleagues working in public health awake at night,” one doctor told The Telegraph.

The new drug has been developed by researchers at Australia’s Griffith University to target and reverse the sepsis, rather than destroy the pathogen that’s causing it. Its recent Phase II human clinical trial in China showed “promising results in reducing sepsis”, said Science Daily. This is “a major step forward”.

What is sepsis?

Essentially, the body’s extreme response to an often minor bacterial, viral, fungal or parasitical infection. Our immune system goes into overdrive trying to fight the infection off, triggering inflammation that can impair blood flow and damage tissues and organs. Without treatment, sepsis can quickly lead to septic shock and multiple organ failure. Anyone can develop sepsis, but it’s more prevalent among the very young, the elderly, the diabetic, the immunocompromised and women who have recently given birth.

If you are treated swiftly, you can make a full recovery. But the longer you wait for a diagnosis, the higher the risk. Sepsis causes more than 10 million deaths a year worldwide: about one person every three seconds.

How is it diagnosed?

Sepsis is often called “the silent killer” because the wide variety of pathogens that can cause it may initially trigger very different symptoms, making it hard for medics to spot soon enough. Warning signs in a child – fever, chills, lethargy, fast heartbeat or breathing, blotchy skin and/or a rash that doesn’t fade (as with meningitis) – can mirror many less serious conditions. For adults, symptoms include slurred speech or confusion, extreme shivering, lack of urination, mottled skin, severe breathlessness and a feeling of doom.

There is currently no one diagnostic test; just different tests, that typically take hours, to confirm the presence, and possibly the type, of infection. The NHS is currently trialling a rapid blood test to identify if a patient has a viral or bacterial infection, which could speed up some diagnoses of sepsis considerably. Doctors who participated in the trial, which concludes in March, have already “witnessed the benefits”, according to The Guardian.

What is the new drug?

Known as STC3141, it is a carbohydrate-based drug administered as an infusion through a cannula. It works by “calming” and counteracting the “major biological molecule release” that occurs during the body’s immune overreaction, and helps to treat sepsis by “reversing the damage to organs rather than only managing symptoms”, said Science Daily.

The research team now plans to move onto Phase III effectiveness trials. “It’s hoped we could see the treatment reach the market in a handful of years, potentially saving millions of lives,” said team leader Mark von Itzstein.

What else might help?

Artificial intelligence may help medics detect sepsis earlier. US researchers at Northeastern University have been training an AI model on patient data collected at urgent care centres, in ambulances and in hospital. The model was able to predict septic shock with over 99% accuracy, according to a study published in Life last October.

“If sepsis is diagnosed in the emergency room, probably the best-case scenario is to pray because the survival rate is extremely low,” lead researcher Sergey Aityan told the university’s Northeastern Global News. “Our system is like an immediate second opinion, which is practically impossible to do in emergency settings with physical doctors.”

There has been a growing demand in recent years to separate “profound autism” into its own diagnosis, outside current parameters.

Since 2013, autism diagnoses have been split into three levels, ranging from “some support required” to “requires very substantial support”, said The Autism Service.

Support for the addition of the “profound autism” category, first proposed in 2022 by a board of international experts in The Lancet, is gaining traction. Some experts think it will bring welcome care to those who require it most, while others say it could mean other members of the autistic community are neglected.

What is profound autism?

The proposed term would describe individuals with autism who “have little or no language (spoken, written, signed or via a communication device), who have an IQ of less than 50, and who require 24-hour supervision and support”, said Kelsie Boulton, Marie Antoinette Hodge and Rebecca Sutherland on The Conversation. This category would only be diagnosable for ages eight and over, when individuals’ “cognitive and communication abilities are considered more stable”.

In their study of 513 autistic children assessed between 2019 and 2024, the researchers found that around 24% of participants met, or were at risk of meeting, the criteria for profound autism.

How has understanding evolved?

US Health Secretary Robert F. Kennedy Jr claimed last autumn that there was an “epidemic” of autism across his country, falsely linking it with vaccines or Tylenol, which is known as paracetamol in the UK. The “unproven and debunked” claims about the causes of autism “threatens public health, even as officials funnel more money into research”, said The Associated Press.

Autism rates have been on the rise “for decades”, but there are solid reasons for this, said The Independent. The diagnosis of autism spectrum disorder, adopted in 2013, is now “very broad”, including many people with low support needs, and there is “better awareness of the condition”, leading to more diagnoses.

The concept of an autistic “spectrum” has been widely accepted since it was coined in the 1980s by psychiatrist Dr Lorna Wing. “Groundbreaking” at the time, her work “transformed how autism was understood in the UK”, said Aimee Grant on The Conversation. Previously, autism had been seen as a “rare, narrowly defined condition”, whereas since a “wide range of traits and experiences” have been recognised.

The introduction of new terms to categorise the spectrum is not without precedent. Wing also introduced the term “Asperger’s syndrome” to the UK. It was intended to divide or categorise patients depending on their care needs. Individuals with Asperger’s tended to have lower support needs.

However, the term was “retired” in the 2013 edition of the Diagnostic and Statistical Manual of Mental Disorders following revelations about Hans Asperger’s links to the Nazi regime, said the National Autistic Society. He was responsible for “abhorrent descriptions of some autistic children as being less ‘worthwhile’ than others”, and “more recent research” has shown that Asperger “was aware that he was sending children to their death”.

Why is the new definition needed?

Having a more specific category in future clinical guidelines could allow governments, disability services and clinicians to plan and deliver support more effectively, said Boulton, Hodge and Sutherland on The Conversation. Due to the broadening of the current spectrum, it is possible that people with the highest needs are “overlooked”, so the new category would “re-balance their under-representation in mainstream autism research”.

Current understanding of an autistic spectrum ranging from “mild” to “severe” can be “misleading”, said Grant. “The term has outlived its usefulness.” The condition has “lots of unique combinations”, including reliance on routine, “stimming” or “monotropism”. “Because autism is made up of all these different elements, there can be no single line on which every autistic person is placed.”

What are the arguments against it?

However, some experts would say the new category is “unhelpful”, said Grant. “It tells us nothing about a person’s particular challenges or the type of support they require.”

Some autistic self-advocates see “unity as the best protection for everyone on the spectrum” and being “part of one shared story”, said Forbes. Similarly, some people in the autistic community fear that creating a separate diagnosis would “reduce attention on the broader spectrum and the individual needs of everyone on it”, said The Independent.

Trying to become pregnant, whether you are struggling with fertility or not, can be an incredibly stressful process. When it comes to conception and nine months of pregnancy, there is plenty of advice for how to be at your healthy best. However, an emerging social media trend has influencers convincing people that the key to a healthy pregnancy lies in how you prepare during the time leading up to it.

What does ‘zero trimester’ mean?

On TikTok and Instagram, the “cultural obsession with wellness and optimization” has come for the “murky preconception period,” coined the “zero trimester” by sociologist Miranda Waggoner in her 2017 book by the same name, Wired said. A growing number of influencers, holistic health experts and even doctors are “posting content that speaks to the ‘Trying to Conceive’ (TTC) demographic,” including “women who are struggling to conceive and those who haven’t started yet.”

Their message is simple: If you “follow this wellness formula,” you will “set yourself up for the quickest conception, the easiest pregnancy and the healthiest child,” said Wired. Essentially, they believe that having a healthy pregnancy boils down to the choices you make before you even become pregnant.

Pregnant women have “long been subject to endless rules on how to treat their bodies,” said The Cut. But increasingly, it feels like the “goal post has been moved back.” The recommendations from zero trimester influencers range from drinking raw milk to filtering air.

The “pregnancy prep” creators encourage lifestyle changes, courses, books and tips to follow during the six to 12 months before becoming pregnant. On her podcast, MAHA influencer Alex Clark recommends that women trying to get pregnant “stop wearing nail polish,” while holistic nutritionists claim it’s important to avoid iced beverages. Other influencers are posting meditation journeys to “lower cortisol six months before trying to conceive,” while some are ordering micronutrient labs and “embarking on 60-day pregnancy-prep detoxes.”

Is the advice worth listening to?

Many people struggle to get pregnant, and some doctors agree that the standard medical advice just to wait and see is failing them. Yet claims “about the importance of trimester-zero strain credulity,” said The Cut. Listening to some of these influencers, it is “easy to come away thinking that if you struggle to get pregnant or have a difficult pregnancy, it’s your fault.”

Some experts argue that the new attention surrounding the zero trimester is a “very positive, exciting development,” as healthy moms “usually spell better outcomes for mom and baby,” said Wired. There are so many things that can be done to “optimize underlying health in that preconception year that will make outcomes in pregnancy better,” Natalie Clark Stentz, an ob-gyn and infertility specialist at Michigan Medicine, said to Wired.

Still, prep should be “expert-vetted and backed by science,” and it “usually doesn’t involve the TikTok Shop,” Wired said. Any “buzzy individual thing is likely sensational,” whether that’s “Brazil nuts, organ meats or whatnot,” Stentz said. Evidence-based recommendations are “not sexy” — suggestions like maintaining a “normal BMI, stop smoking, pick a boring prenatal vitamin.”

Pregnancy prep regimens being touted by influencers can also “get pricey fast,” Wired said. They are taking a “very vulnerable, very highly motivated population of patients” and targeting them with “information that is kind of driven by financial incentives,” Kara Goldman, an ob-gyn and associate professor of reproductive endocrinology and infertility at Northwestern University, said to Wired. The marketing can “disguise the fact that even going into pregnancy in peak health is not a guarantee,” said the outlet.

The zero trimester trend can “make women feel guilty or blame-worthy if their outcome isn’t ‘perfect,’ however they’re defining perfect,” said Waggoner. It promotes the idea that there is a “causal and deterministic link between preconception care behaviors and birth outcomes,” and that is what “can be problematic for both individuals and at a policy level.”

Most Americans may not expect a robot to perform their surgery, but AI-powered surgical tools are becoming more ubiquitous in operating rooms. While these tools are only used to assist human surgeons during operations and don’t perform surgery themselves, recent investigations, along with several lawsuits, are causing some medical experts to reconsider the use of AI in hospitals.

What kind of surgical tools are powered by AI?

At least 1,357 AI-integrated medical devices are “now authorized by the FDA — double the number it had allowed through 2022,” said Reuters as part of an investigation into AI-assisted surgery. One of the most notable is the TruDi Navigation System, a device manufactured by Johnson & Johnson that uses a “machine-learning algorithm to assist ear, nose and throat specialists in surgeries.” Other AI-assisted devices are designed for surgeries on other parts of the body.

Many of these tools address the “area of vision enhancement,” said Forbes. Traditional laparoscopic surgery “presents surgeons with significant challenges: smoke obscures the surgical field, two-dimensional images make depth perception difficult and critical anatomical structures can be hard to distinguish.” AI surgical tools can eliminate these obstacles and provide surgeons with “crystal-clear views of the operative field.”

What has the result been?

There has been an influx of allegations and lawsuits against various AI tools, many of which claim these tools actively harmed patients. Several of these involve the TruDi tool, as the FDA has “received unconfirmed reports of at least 100 malfunctions and adverse events” related to the device’s AI, said Reuters. Many of the alleged errors occurred when the AI “misinformed surgeons about the location of their instruments while they were using them inside patients’ heads.”

In one case, this reportedly led to cerebrospinal fluid leaking from a patient’s nose, while in another case, a surgeon “mistakenly punctured the base of a patient’s skull,” said Reuters. Two other cases allegedly led to patients suffering strokes after major arteries were accidentally injured; in at least one of these cases, the plaintiff said the TruDi’s AI “misled” the surgeon, causing him to “injure a carotid artery, leading to a blood clot and eventually a stroke,” said Futurism.

FDA reports on malfunctioning devices “aren’t intended to determine causes of medical mishaps, so it’s not clear what role AI may have played in these events,” said Reuters. But TruDi is not the only AI-assisted medical device that allegedly has performance issues. One machine that analyzes prenatal images using AI, the Sonio Detect, has been “accused of using a faulty algorithm” that “misidentifies fetal structures and body parts,” said Tom’s Hardware. And Medtronic, a company that manufactures AI-assisted heart monitors, has faced allegations that its monitors “failed to recognize abnormal rhythms or pauses in patients.”

Overall, at least 60 AI-assisted medical devices have been linked to 182 product recalls by the FDA, according to research published in JAMA Health Forum. At least 43% of these recalls “occurred within the first 12 months” of the device’s FDA approval, said JAMA. This suggests that the FDA’s approval process “may overlook early performance failures of AI technologies.” But there is hope that the issue can be fixed, as shoring up “premarket clinical testing requirements and postmarket surveillance measures may improve identification and reduction of device errors.”